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Abstract 
Many functional food related bioactive compounds have been discovered and draw the 
attention of scientists. This dissertation focused on sorghum phenolic compounds and omega-3 
polyunsaturated fatty acids. 
Study 1: phenolic agents in plant foods have been associated with chronic disease 
prevention, especially cancer. However, a direct evidence and the underlying mechanisms are 
mostly unknown. This study selected 13 sorghum accessions and was aim to investigate: (1) the 
effect of extracted sorghum phenolics on inhibiting cancer cell growth using hepatocarcinoma 
HepG2 and colorectal adenocarcinoma Caco-2 cell lines; (2) and the underlying mechanisms 
regarding cytotoxicity, cell cycle interruption, and apoptosis induction. Treatment of HepG2 and 
Caco-2 cells with the extracted phenolics at 0-200 M GAE (Gallic acid equivalent) up to 72 hrs 
resulted in a dose- and time-dependent reduction in cell number. The underlying mechanism of 
cell growth inhibition was examined by flow cytometry, significant inverse correlations were 
observed between the decreased cell number and increased cell cycle arrest at G2/M or induced 
apoptosis cells in both HepG2 and Caco-2 cells. The cytotoxic assay showed that the sorghum 
phenolic extracts were non-toxic. Although it was less sensitive, a similar inhibitory impact and 
underlying mechanisms were found in Caco-2 cells. These results indicated for the 1st time that a 
direct inhibition of either HepG2 or Caco-2 cell growth by phenolic extracts from13 selected 
sorghum accessions was due to cytostatic and apoptotic but not cytotoxic mechanisms. In 
addition, these findings suggested that sorghum be a valuable functional food by providing 
sustainable phenolics for potential cancer prevention. 
Study 2: omega-3 polyunsaturated fatty acids (ω-3 PUFAs) especially long-chain ω-3 
PUFAs, have been associated with potential health benefits in chronic disease prevention. 
  
However, the conversion rate from short- to long-chain ω-3 PUFAs is limited in human body. 
This study was aim to assess the modification of fatty acid profiles as well as investigate the 
conversion of short- to long-chain ω-3 PUFAs in the liver of Shan Partridge duck after feeding 
various dietary fats. The experimental diets substituted the basal diet by 2% of flaxseed oil, 
rapeseed oil, beef tallow, or fish oil, respectively. As expected, the total ω-3 fatty acids and the 
ratio of total ω-3/ ω-6 significantly increased in both flaxseed and fish oil groups when compared 
with the control diet. No significant change of total saturated fatty acids or ω-3 fatty acids was 
found in both rapeseed and beef tallow groups. Short-chain ω-3 α-linolenic acid (ALA) in 
flaxseed oil-fed group was efficiently converted to long-chain ω-3 docosahexaenoic acid (DHA) 
in the duck liver. This study showed the fatty acid profiling in the duck liver after various dietary 
fat consumption, provided insight into a dose response change of ω-3 fatty acids, indicated an 
efficient conversion of short- to long-chain ω-3 fatty acid, and suggested alternative long-chain 
ω-3 fatty acid-enriched duck products for human health benefits. 
             In conclusion, the two studies in this dissertation provided a fundamental understanding 
of anti-cancer activity by sorghum phenolic extracts and the conversion of short- to long-chain 
ω-3 PUFAs in duck liver, contribute to a long term goal of promoting sorghum and duck as 
sustainable phenolic and ω-3 PUFAs sources as well as healthy food products for human beings. 
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Abstract 
Many functional food related bioactive compounds have been discovered and draw the 
attention of scientists. This dissertation focused on sorghum phenolic compounds and omega-3 
polyunsaturated fatty acids. 
Study 1: phenolic agents in plant foods have been associated with chronic disease 
prevention, especially cancer. However, a direct evidence and the underlying mechanisms are 
mostly unknown. This study selected 13 sorghum accessions and was aim to investigate: (1) the 
effect of extracted sorghum phenolics on inhibiting cancer cell growth using hepatocarcinoma 
HepG2 and colorectal adenocarcinoma Caco-2 cell lines; (2) and the underlying mechanisms 
regarding cytotoxicity, cell cycle interruption, and apoptosis induction. Treatment of HepG2 and 
Caco-2 cells with the extracted phenolics at 0-200 M GAE (Gallic acid equivalent) up to 72 hrs 
resulted in a dose- and time-dependent reduction in cell number. The underlying mechanism of 
cell growth inhibition was examined by flow cytometry, significant inverse correlations were 
observed between the decreased cell number and increased cell cycle arrest at G2/M or induced 
apoptosis cells in both HepG2 and Caco-2 cells. The cytotoxic assay showed that the sorghum 
phenolic extracts were non-toxic. Although it was less sensitive, a similar inhibitory impact and 
underlying mechanisms were found in Caco-2 cells. These results indicated for the 1st time that a 
direct inhibition of either HepG2 or Caco-2 cell growth by phenolic extracts from13 selected 
sorghum accessions was due to cytostatic and apoptotic but not cytotoxic mechanisms. In 
addition, these findings suggested that sorghum be a valuable functional food by providing 
sustainable phenolics for potential cancer prevention. 
Study 2: omega-3 polyunsaturated fatty acids (ω-3 PUFAs) especially long-chain ω-3 
PUFAs, have been associated with potential health benefits in chronic disease prevention. 
  
However, the conversion rate from short- to long-chain ω-3 PUFAs is limited in human body. 
This study was aim to assess the modification of fatty acid profiles as well as investigate the 
conversion of short- to long-chain ω-3 PUFAs in the liver of Shan Partridge duck after feeding 
various dietary fats. The experimental diets substituted the basal diet by 2% of flaxseed oil, 
rapeseed oil, beef tallow, or fish oil, respectively. As expected, the total ω-3 fatty acids and the 
ratio of total ω-3/ ω-6 significantly increased in both flaxseed and fish oil groups when compared 
with the control diet. No significant change of total saturated fatty acids or ω-3 fatty acids was 
found in both rapeseed and beef tallow groups. Short-chain ω-3 α-linolenic acid (ALA) in 
flaxseed oil-fed group was efficiently converted to long-chain ω-3 docosahexaenoic acid (DHA) 
in the duck liver. This study showed the fatty acid profiling in the duck liver after various dietary 
fat consumption, provided insight into a dose response change of ω-3 fatty acids, indicated an 
efficient conversion of short- to long-chain ω-3 fatty acid, and suggested alternative long-chain 
ω-3 fatty acid-enriched duck products for human health benefits. 
In conclusion, the two studies in this dissertation provided a fundamental understanding 
of anti-cancer activity by sorghum phenolic extracts and the conversion of short- to long-chain 
ω-3 PUFAs in duck liver, contribute to a long term goal of promoting sorghum and duck as 
sustainable phenolic and ω-3 PUFAs sources as well as healthy food products for human beings. 
 
  
  viii 
Table of Contents 
List of Figures ................................................................................................................................. x 
List of Tables ................................................................................................................................ xii 
Acknowledgements ...................................................................................................................... xiii 
Preface.......................................................................................................................................... xiv 
Chapter 1 - Literature review .......................................................................................................... 1 
Summary ..................................................................................................................................... 1 
Part 1 Sorghum phenolic compounds, their anti-cancer mechanisms and effect of on cancer 
cells in vitro ................................................................................................................................ 1 
Sorghum phenolic compounds ................................................................................................ 1 
Cancer prevention mechanism of phenolic compounds ......................................................... 4 
Anti-cancer effect of sorghum phenolic compounds in vitro ............................................... 11 
Part 2 Omega-3 polyunsaturated fatty acids and their health benefit as well as metabolism, 
conversion in vivo especially in duck model ............................................................................ 12 
Introduction to omega-3 PUFAs ........................................................................................... 12 
Health benefit of long-chain omega-3 PUFAs ...................................................................... 13 
Metabolism of omega-3 fatty acids ....................................................................................... 14 
Omega-3 PUFAs in animal models ...................................................................................... 17 
Omega-3 PUFAs in duck model ........................................................................................... 18 
Reference .................................................................................................................................. 20 
Chapter 2 - Sorghum phenolic compounds are associated with cell growth inhibition through cell 
cycle arrest and apoptosis induction in human hepatocarcinoma HepG2 and colorectal 
adenocarcinoma Caco-2 cells ................................................................................................ 48 
Abstract ..................................................................................................................................... 49 
1. Introduction ........................................................................................................................... 63 
2. Material and methods ............................................................................................................ 65 
3. Result .................................................................................................................................... 69 
4. Discussion ............................................................................................................................. 71 
References ................................................................................................................................. 75 
  ix 
Chapter 3 - Effect of Various Dietary Fats on Fatty Acid Profile in Duck Liver: Efficient 
Conversion of Short-chain to Long-chain Omega-3 Fatty Acids .......................................... 87 
Abstract ..................................................................................................................................... 88 
Introduction ............................................................................................................................... 89 
Material and methods ................................................................................................................ 91 
Results ....................................................................................................................................... 94 
Discussion ................................................................................................................................. 95 
Reference .................................................................................................................................. 98 
Chapter 4 - Conclusions .............................................................................................................. 112 
Chapter 5 - Future plan ............................................................................................................... 113 
  
  x 
List of Figures 
Figure 1-1 Structure of flavonoids, phenolic acids and tannins.1 ................................................. 37 
Figure 1-2 Structures of stilbene and lignan.1 ............................................................................... 38 
Figure 1-3 Diagram of sorghum caryopsis showing the pericarp [cutin, epicarp, mesocarp, tube 
cells, cross cells, testa, pedicel, and stylar area (SA)], endosperm (E) (aleurone layer, 
corneous, and floury), and germ [scutellum (S) and embryonic axis (EA)].141 .................... 39 
Figure 1-4 Structures of simple phenols and phenolic acids found in sorghum.9,10,14 .................. 40 
Figure 1-5 Structure of some sorghum flavanols.14 ...................................................................... 41 
Figure 1-6  The main sorghum anthocyanidins and 3-deoxyanthocyanidin.14,21 .......................... 42 
Figure 1-7 Structure of condensed tannins in sorghum.7,14........................................................... 43 
Figure 1-8 Levels of different cyclins in different cell cycle phases and regulation of different 
cell cycle phases by different cyclin-CDK complexes.46 ...................................................... 44 
Figure 1-9 Schematic diagram showing targets of same natural phenolic compounds in part of 
cell cycle regulatory network.46 ............................................................................................ 45 
Figure 1-10 Structure of representative omega-3 PUFAs. ............................................................ 46 
Figure 1-11 Conversion from ALA to EPA and DHA. ALA is converted to EPA through a 
sequential action of Δ-6 fatty acid desaturase, elongase, and Δ-5 desaturase. ..................... 47 
Figure 2-1 The effect of various sorghum phenolic extracts at 0-200 μM GAE on cell number in 
HepG2 cells after 72 hrs. ...................................................................................................... 83 
Figure 2-2 The effect of representative sorghum phenolic extracts at 0-200 μM GAE on cell 
number in both HepG2 and Caco-2 cells for up to 72 hrs. ................................................... 84 
Figure 2-3 Cytostatic effect of representative sorghum phenolic extracts in HepG2 and Caco-2 
cell lines. ............................................................................................................................... 85 
Figure 2-4 Percentage of dead cells induced by representative sorghum phenolic extracts in 
HepG2 and Caco-2 cell lines. ............................................................................................... 86 
Figure 3-1 Representative Gas Chromatography of fatty acid profile in the liver of ducks fed 
with various dietary fats for 5 weeks. ................................................................................. 109 
Figure 3-2 Dose response of ω-3 fatty acids in the liver of ducks fed with various doses of 
flaxseed oil or fish oil for 5 weeks. ..................................................................................... 110 
  xi 
Figure 3-3 Dose response of total ω-3/ω-6 ratio in the liver of ducks fed with various disease of 
flaxseed oil or fish oil for 5 weeks. ..................................................................................... 111 
 
  
  xii 
List of Tables 
Table 2-1 Phenolic Contents in Various Sorghum Accessions .................................................... 78 
Table 2-2 IC50 Values of sorghum phenolic extracts in HepG2 and Caco-2 cells ...................... 79 
Table 2-3 Correlation coefficient (r) among total phenolic contents with IC50 values from the 
phenolic extracts of 13 sorghum accessions in HepG2 cells, or cell number with cell cycle 
arrest and cell death from control, PI329694 and PI570481 in both cell lines. .................... 80 
Table 3-1 Composition and main characteristics of the basal diet. ............................................ 104 
Table 3-2 Measured fatty acids in the experimental diets. ......................................................... 105 
Table 3-3 Fatty acid contents in the duck liver fed various dietary fats for 5 weeks.* .............. 106 
Table 3-4 Fatty acid contents of duck liver fed various dose of dietary fats for 5 weeks.* ....... 107 
 
  
  xiii 
Acknowledgements 
I would like to express my sincere gratitude to my major professor, Dr. Weiqun Wang for 
his continuous encouragement, valuable advice, and insightful guidance during my PhD period 
in Department of Food Nutrition Dietetics and Health at Kansas State University. What I learned 
from Dr. Wang, such as his persistent focus to the science and enthusiasm attitude, would 
become to the fortune to lead my future study and work.  Three and a half years ago, I feel so 
lucky and excited to join Dr. Wang’s Cancer Research Lab, I was trained to be a qualified 
scientist, and now I appreciate every day I worked here. I would also like to thank Dr. Donghai 
Wang, Dr. Yongcheng Shi, Dr. Weixing Song, and Dr. Timothy Durrett for their interest to serve 
as my supervisory committee and providing valuable suggestions. 
An expression of appreciation and thanks to all my fellows in Dr. Wang’s research group, 
Miao Yu, Xiaoyu Su, Yanting Shen, Jingwen Xu for their help and friendship. Also, I would like 
to thank my dear friends Dr. Ting Luo for her continuously support and sincere friendship. 
Further thanks go to all the staff and graduate students in FNDH Department for their help and 
support. 
At last, I deeply express my appreciation and gratitude to my parents and my husband Dr. 
Xiangwei Zhu, who give me unconditional and everlasting love. Thank you.  
 
  xiv 
Preface 
 
This dissertation is original work completed by the author, Xi Chen. Chapter 2 
was formatted for publication according to required standards of the journal: Nutrition 
Research. Chapter 3 was formatted for publication according to the required standards 
of the journal: Experimental Biology and Medicine. 
  
  1 
Chapter 1 - Literature review 
Summary 
Functional food related bioactive compounds such as omega-3 polyunsaturated fatty acids 
(PUFAs) and phenolic compounds are reported to have the potential to provide health benefits to 
human beings. Compelling data shows they are associated with chronic diseases including 
cardiovascular disease, inflammatory diseases, type-2 diabetes, and cancers etc. However, humans 
cannot synthesis omega-3 polyunsaturated fatty acids or phenolic compounds in their body, these 
compounds must be obtained from foods. This review falls into two parts: 1) the first part reviews 
the background information of sorghum phenolic compounds, associated cancer prevention 
mechanisms, and effect on cancer cells in vitro; 2) the second part introduces some background 
information of omega-3 polyunsaturated fatty acids, their health benefits and the mechanism of 
the conversion from short- to long- chain omega-3 PUFAs followed by their application in animal 
models in vivo especially duck model.  
Part 1 Sorghum phenolic compounds, their anti-cancer mechanisms and effect 
of on cancer cells in vitro 
 Sorghum phenolic compounds 
Phenolic compounds are phytochemicals possessing one or more aromatic rings with one 
or more hydroxyl groups. They are broadly distributed in the plant kingdom and are the most 
abundant secondary metabolites of plants, with more than 8,000 phenolic structures currently 
known, ranging from simple molecules such as phenolic acids to highly polymerized substances 
such as tannins. Plant phenolics include phenolic acids, flavonoids, tannins (Figure 1-1) and the 
less common stilbenes and lignans (Figure 1-2).1 
  2 
Sorghum is a major cereal food crop used in many parts of the world. Sorghum caryopsis 
consists of three distinct anatomical components (Figure 1-3)2: pericarp (outer layer), endosperm 
(storage tissue), and germ (embryo). All sorghums contain phenolic compounds, the amount 
present in any particular cultivar is influenced by its genotype and the environment in which it is 
grown. In addition, these same factors affect the color, appearance, and nutritional quality of the 
grain and its products.3 Among cereals, sorghum has the highest content of phenolic compounds 
reaching up to 6% (w/w) in some varieties.4,5 Sorghums with a pigmented testa and spreader genes 
(B1B2S) or with purple/red plants and thick pericarp genes have the highest levels of phenolic 
compounds.3 The main classes of sorghum phenolic compounds are simple phenols, 
hydroxybenzoic acids, hydroxycinnamic acids, flavonoids (flavanols, flavones, flavanones, 
isoflavones and anthocyanins), chalcones, aurones (hispidol), hydroxycoumarins, lignans, 
hydroxystilbenes and polyflavans (proanthocyanidins and pro- deoxyanthocyanidins).6,7 These 
compounds are soluble in water or organic solvents (methanol, HCl-methanol, acetone, 
dimethylformamide, etc.). Lignans and hydroxystilbenes have not been detected in sorghum 
grain.5 
Simple phenols and phenolic acids 
Simple phenols are relatively rare in plants. Catechol and resorcinol were reported in 
sorghum grain,8,9 these compounds are undesired in food products because they are carcinogenic, 
hepatotoxic and goitrogenic.10 The phenolic acids of sorghum are largely exist as benzoic or 
cinnamic acid derivatives (hydroxybenzoates and hydroxycinnamates) (Figure 1-4), they are 
mostly found in free form or bound as esters, and are concentrated in the bran (outer covering of 
grain), and mostly in bound forms (esterified to cell wall polymers), with ferulic acid being the 
most abundant bound phenolic acid in sorghum.11 Several other phenolic acids also have been 
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identified in sorghum including syringic, protocatechuic, caffeic, p-coumaric, and sinapic.12 
Flavonoids 
Flavonoids constitute the largest class of phenolic compounds with more than 3000 
structures, possessing in common a flavylium unit (C6-C3-C6).
13 Sorghum contains flavonoids 
such as flavanols (flavan-3-ols, flavan-4-ols, etc., Figure 1-5), flavanones, flavones and 
anthocyanins.14 The flavan-4-ols apiforol (pro-apigeninidin or leuco-apigeninidin) and tuteoforol 
(proluteolinidin or leuco-luteolinidin) are abundant in sorghum,15 and precursors of apigeninidin 
and luteolinidin, respectively.16 Sorghums with a black pericarp have higher levels flavan-4-ols 
and anthocyanins than the other varieties.3,17 The most common anthocyanins in sorghum are the 
3-deoxyanthocyanidins, which include apigeninidin and luteolinidin (Figure 1-6).18 The red color 
of the grain’s pericarp is essentially due to the presence of 3-deoxyanthocyanidins.19 The 3-
deoxyanthocyanidins (3-DAs), are particularly abundant in notably red sorghum grain,15 but rare 
or absent in other plants.14,20,21 3-DAs are of interest because they are more stable in organic 
solvents as well as in acidic solutions than anthocyanidins commonly found in fruits, vegetables 
and other cereals.20,21 This has been suggested as a potential advantage of sorghum as a viable 
commercial source of anthocyanins.14 
Condensed tannins 
Tannins of sorghum are almost exclusively of the ‘‘condensed’’ type. They are mainly 
polymerized products of flavan-3-ols (proanthocyanidins) and/or flavan-3,4-diols (pro-3-
deoxyanthocyanidins, Figure 1-7).14 No sorghum varieties contain tannic acid and hydrolysable 
tannins.5 Sorghum proanthocyanidins consist of flavan-3-ol units linked by C-C (type B 
proanthocyanidins) and occasionally C-O-C (type A proanthocyanidins) bonds ranging from one 
to fifteen.7,14 The most abundant condensed tannins in sorghum are homopolymers of 
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catechin/epicatechin with uniform B-type interflavan bonds,7 however, not all sorghum varieties 
contain these because their content is genetically governed by B1-B2 genes.22 In general, varieties 
with pigmented testa layers contain proanthocyanidins.15,23 The main pro-deoxyanthocyanidins 
found in sorghum are pro-apigeninidins and pro-luteolinidins (Figure 1-7). Although present in 
sorghum, these compounds are very rare in other plants. Hydrolysis of pro- apigeninidins and pro-
luteolinidins yields apigeninidins and luteolinidins, respectively.24 
 Cancer prevention mechanism of phenolic compounds 
Phenolic agents in plant foods have been associated with chronic disease prevention, 
especially cancer. It was found that in addition to their antioxidant activity, this group of 
compounds displays a wide variety of biological functions which are mainly related to modulation 
of carcinogenesis. To understand the mechanisms of action of phenolic compounds in preventing 
cancer, first we need to know how cancer arises. 
Causes of cancer 
Cancer development is a multistage process that involves a series of individual steps 
including initiation, promotion, progression, invasion and metastasis. Tumor initiation begins 
when DNA, in a cell or population of cells, is damaged by exposure to carcinogens, which are 
derived from three major sources: cigarette smoking, infection/inflammation, and nutrition/diet.25 
The process of carcinogenesis can be broadly categorized into three distinct phases: tumor 
initiation, promotion and progression. Genetic mutation take place when DNA damage escapes 
repairing. The resulting somatic mutation in a damaged cell can be reproduced during mitosis, 
which given rise to a clone of mutated cells. Tumor promotion is a selective clonal expansion of 
the initiated cells to form an actively proliferating multi-cellular premalignant tumor cell 
population. It is an interruptible or reversible and long term process. During progression, 
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premalignant cells developed into tumors through a process of clonal expansion. In the late stages 
of cancer development, invasion and metastasis happens, where tumor cells detach from the 
primary tumor mass, migrate through surrounding tissues toward blood vessels or lymphatic 
vessels, and create a second lesion. Metastasis is the major cause of cancer mortality. It is widely 
accepted that human cancer development does not occur through these discrete phases in a 
predictable manner, rather it is best characterized as an accumulation of alteration in cancer 
regulating genes,26 such as oncogenes, tumor suppressor genes, resulting in altered cellular 
processes, namely, decreased apoptosis, increased proliferation, and cell maturation and 
differentiation.  
Phenolic compounds, appear to play a significant role in suppressing all three stages of 
tumor formation and metastasis, including the transformative, hyper-proliferative and 
inflammatory processes involved in initiation, the angiogenic processes required for tumor growth 
as well as the vascular adhesive properties necessary for metastasis or tumor dispersion.27 
Mechanisms of phenolic compounds in cancer prevention 
Alteration of pro-carcinogenic metabolism by phenolics 
In the initiation stage, phenolics may inhibit activation of procarcinogens by inhibiting 
phase I metabolizing enzymes, such as cytochrome P45028 and also facilitate detoxifying and 
elimination of the carcinogens by induction of phase II metabolizing enzymes such as glutathione 
S-transferase (GST), NAD(P)H quinine oxidoreductase (NQO), and UDP-glucuronyl- transferase 
(UGT).29 They may also limit the formation of the initiated cells by stimulating DNA repair.30 
          Phenolics as potent antioxidants in oxidation 
ROS/RNS are constantly produced during normal cellular metabolism or by other 
exogenous means including the metabolism of environmental toxins or carcinogens, by ionizing 
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radiation and by phagocytic cells involved in the inflammatory response. When the cellular 
concentration of oxidant species is increased to an extent that overcome the endogenous 
antioxidant defense system, oxidative stress occurs, leading to lipid, protein, and DNA damage. In 
addition, ROS, particularly H2O2, are potent regulators of cell replication and play an important 
role in signal transduction.31 Hence, oxidative damage is considered a main factor contributing to 
carcinogenesis and evolution of cancer. Numerous dietary phenolics are potent antioxidants, 
capable of scavenging deleterious reactive species such as superoxide anions, singlet oxygen 
hydroxy radicals, nitric oxide and peroxynitrite.32–36 Various phenolics are also able to attenuate 
ROS generation through inhibition of redox sensitive transcription factors such as NF‐kB and AP‐
1 respon‐ sible for the expression of the ROS‐induced in ammatory enzyme cascade. Xanthine 
oxidase, COX‐II and LOX were shown to be reduced by dietary phenolics like curcumin, silymarin 
and resveratrol. Polyphenols can also induce detoxifying enzymes such as glutathione‐S‐
transferase (GST) and quinone reductase (QR) which can protect cells from carcinogenic 
intermediates, exogenous or endogenous.32–34,37–40 
Historically, the anti-cancer effects of phenolic compounds have been mostly explained 
through their antioxidant potentials, but this seems very complicated. There is evidence 
manifesting risky effects of antioxidants rather than their benefits in patients suffering from 
cancer.41,42 Therefore, it is essential to differentiate and clarify antioxidant and anti-cancer actions 
of these compounds in order to help clinicians to establish new strategies for prevention and 
treatment of cancer.  
Besides antioxidant activity, several other important mechanisms as follows also contribute 
to anti-cancer effect of phenolic compounds. 
Phenolics as potent inhibitors of Growth Factors and Receptors (GFRs)  
  7 
Plant phenolics such as curcumin, genistein, resveratrol and catechins are potent inhibitors 
of a number of growth factors binding and signaling pathways implicated in cancer. Growth factors 
are proteins that bind to specific receptors on cell surfaces to elicit a signaling cascade responsible 
for the normal activation of cell proliferation/differentiation required for tissue growth and repair. 
Aberrant growth factor expression/availability results in a signaling cascade leading to 
uncontrolled cell proliferation and differentiation, suppression of apoptotic signals and ultimately 
in carcinogenesis, tumor growth/progression and metastasis.32–35 Major growth factors implicated 
in carcinogenesis are epidermal growth factor (EGF), plate-derived growth factor (PDGF),  
fibroblast growth factors (FGFs), transforming growth factors-α and ‐β (TGFs‐α and ‐β), insulin‐
like growth factor (IGF), erythropoietin (EPO), as well as the inflammation‐related cytokines 
interleukin1,‐2,‐6,‐8 (IL‐1,‐2,‐6,‐8), tumor necrosis factor‐α (TNF‐α), interferon‐γ (IFN‐γ) and 
colony stimulating factors (CSFs).33–35 The binding of these factors to their specific receptors 
elicits powerful cell proliferation signals through the activation of signal cascades involving 
various receptor-regulated and cytosolic kinases and transcription factors which forms the basis of 
growth factor/receptor driven carcinogenesis and tumor progression.33–35 Compounds such as 
phenolic compounds that can attenuate GF binding and the attendant signal cascade are generally 
regarded as excellent chemo-preventive agents.  
Regulation of cell cycle and apoptosis by phenolics 
Disruption of the normal regulation of cell-cycle progression and division are important 
events in the development of cancer. The cell cycle is the recurring sequence of events that includes 
the duplication of cell contents and subsequent cell division. For eukaryotic cells, the cell cycle 
has been defined as the interval between the completion of mitosis in a cell and the completion of 
mitosis by one or both of its daughter cells.43 Traditionally the cell cycle in eukaryotic cell has 
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been divided into four phases: Gap phase 1 (G1); DNA synthesis (S); Gap phase 2 (G2), during 
which the cell prepares itself for division; and mitosis (M) during which the chromosomes separate 
and the cell divides.43,44 The progression of cell cycle from one phase to the next is regulated by 
sequential activation and inactivation of many “check points” that monitor the status of the cell as 
well as environmental cues.45 Cyclin:cyclin-dependent kinase complexes control the two critical 
checkpoints in the cell cycle at the G1/S and G2/M transitions by phosphorylating a variety of 
proteins such as nuclear lamins and histones for nuclear membrane breakdown and chromosome 
condensation, as well as proteins leading to the transcription of genes required for proliferation.44 
Different cell-cycle phases are associated with production of distinct types of cyclins. In contrast 
to CDKs, having constant level during cell cycle, the level of regulatory subunits and cyclins rises 
and falls in different cell-cycle phases (Figure 1-8).46 Passage through the cell cycle is governed 
by cyclin-dependent kinases (cdks) which complex with their "partner" cyclins.47 The G1 cyclins 
and their associated cdks regulate the G1/S transition. Cyclins D1, D2 and/or D3 are expressed in 
early G1 phase, and cyclin E is expressed in late G1 phase. D-type cyclins complexed with cdk2, 
4 or 6 promote cell cycle progression by phosphorylating a variety of substrates such as the 
retinoblastoma (Rb) protein, which is required for entry into S phase. The mitotic cyclins, first 
discovered as proteins with abundant oscillation in early invertebrate embryonic cell cycles, form 
complexes with cdks and regulate the G2/M transition. In most organisms, B-type cyclins function 
as a subunit of the major mitotic protein kinase.47 
The chemical structures of phenolic compounds are widely diverse from simple phenols to 
tannins. Presence of phenolic hydroxyl groups allows them to cause some interactions with 
proteins changing their functions. They share a phenolic proton in hydrogen bonds with a special 
functional group of proteins such as amide, guanidine, peptide amino or carboxyl groups.46 This 
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ability provides several mechanisms for phenolic compounds to prevent or cure cancer. They 
interact with specific proteins to regulate cell cycle and consequently modulate cellular 
proliferation. Therefore, they have potential to control cell cycle progression in cancer cells via 
targeting various components in the cell cycle regulatory network.46,48 For instance, Treatment of 
various cancer cells (prostate, lung and skin) with EGCG altered the pattern of cell cycle proteins; 
specifically the inhibition of CDKs. EGCG also enhances the expression of CDKI proteins, such 
as Cip1/p21 and Kip1/p27 while reducing the expression of cyclin D1 and the phosphorylation of 
retinoblastoma protein. EGCG causes cell cycle arrest and promotes apoptosis via a dose- and 
time-dependent upregulation of Cip1/p21, Kip1/p27, and p16/INK4A and down-regulation of 
proteins such as cyclin D1, cyclin E, CDK2, and CDK4.49 EGCG caused growth arrest at G1 stage 
of cell cycle through regulation of cyclin D1, CDK4, CDK6, Cip1/p21 and Kip1/p27, and induced 
apoptosis through generation of reactive oxygen species and activation of caspase-3 and caspase-
9.50 Apoptosis, or programmed cell death, is an important mechanism in normal development and 
in anticancer surveillance. The process is regulated by various oncogenes/proteins, including the 
important pro‐apoptotic p53, the anti‐apoptotic and cell survival Bcl‐2 and the caspase cascade.33–
35,43 The regulation of cell cycle and apoptosis by other natural phenolic compounds such as gallic 
acid, coumarin, genistein etc. are summarized in Figure 1-9.46 
Mediation of inflammatory process by phenolics 
One important aspect of carcinogenesis is recognized to be the involvement of 
inflammation. For instance, prostaglandins are mediators of inflammation and chronic 
inflammation predisposes to carcinogenesis. The over-expression of inducible cyclooxygenases 
(COX-2), the enzyme which catalyzes a critical step in the conversion of arachidonic acid to 
prostaglandins and is induced by pro-inflammatory stimuli, including mitogens, cytokines and 
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bacterial lipopolysaccharide (LPS), is believed to be associated with colon, lung, breast and 
prostate carcinogenesis. Natural phenolics have been reported to inhibit transcription factors 
closely linked to inflammation (e.g., NF-κB),51,52 pro-inflammatory cytokines release51,53 and 
enzymes such as COX-254, lipoxygenases (LOX)55, inducible nitric oxide synthase (iNOS)56 that 
mediate inflammatory processes, both in vitro and in vivo.57 In many cases, polyphenols exhibit 
anti-inflammatory properties through blocking MAPK-mediated pathway. Furthermore, a few 
structure-activity studies have been conducted. For example, Hou et al. examined the inhibitory 
effects of five kinds of green tea proanthocyanidins on cyclooxygenase-2 (COX-2) expression and 
PGE-2 release in LPS-activated murine macrophage RAW-264 cells.54 It was revealed that the 
galloyl moiety of proanthocyanidins appeared important to their inhibitory actions. Another study 
by Herath et al. suggested that the double bond between carbon 2 and 3 and the ketone group at 
position 4 of flavonoids are necessary for potent inhibitory effects on LPS-induced tumor necrosis 
factor-alpha (TNF-α) production in mouse macrophages (J774.1).58 
Suppression of angiogenesis by phenolics 
As stated previously, angiogenesis, or new blood vessel formation, is vital for supplying 
nutrients and oxygen to the tumor and ensuring its growth and progression, its invasiveness and 
spread to other tissues. Prevention of angiogenesis would “starve” the tumor and prevent 
metastasis.32–34,59,60 Consequently, angiogenesis inhibition is an active objective in current 
anticancer research. Quercetin, genistein, resveratrol and various phenolic acids are capable of 
inhibiting angio‐ genesis in in vitro cell‐based systems as well as in animal models. These effects 
appear to be due to attenuation of matrixmetalloproteinases (MMPs) inhibition of VEGF and their 
Src kinases.33,59 These phenolics have also been shown to attenuate the expression of vascular 
adhesion molecules which would reduce the metastatic process.34,37 
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 Anti-cancer effect of sorghum phenolic compounds in vitro 
Phenolic extracts or isolated phenolics from different plant food have been studied in many 
cell lines. For example, berry extracts prepared from blackberry, raspberry, blueberry, cranberry, 
and strawberry including anthocyanins, kaempferol, quercetin, esters of coumaric acid and ellagic 
acid, were shown to inhibit the growth of human oral (KB, CAL-27), breast (MCF-7), colon (HT-
29, HCT-116), and prostate (LNCaP, DU-145) tumor cell lines in a dose-dependent manner with 
different sensitivity between cell lines.61,62 Similar results have also been reported with wine 
extracts63, tea extracts and major green tea polyphenols64. Other phenolic extracts from legumes65, 
citrus66 and apples67 were also studies. 
However, studies regarding the anti-cancer effect of sorghum phenolic compounds in vitro 
are scarce. A few studies published recently used sorghum extracts to treat various cancer cells. 
Suganya Devi68 used breast cancer cell line (MCF-7) to evaluate the anti-proliferative activity of 
red sorghum bran anthocyanin, and found that the red sorghum anthocyanin induced growth 
inhibition of MCF-7 cells at significance level. Similar results were also found using other cancer 
cell lines including leukemia (HL-60)69, breast (MDA-MB 231)70, colon (HT-29)71 and liver 
(HepG2)71 cells as inducing cell apoptosis, inhibiting cell proliferation, promotion the expression 
of cell cycle regulators and p53 gene by sorghum extracts. In vitro data is the first and necessary 
step to understand the underlying mechanisms of anti-cancer effect of sorghum phenolic 
compounds. The lag of sorghum phenolic compounds behind similar research on other plant food 
drives us to investigate the effect of sorghum phenolic compounds in cancer cell growth inhibition 
and the underlying mechanisms.  
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Part 2 Omega-3 polyunsaturated fatty acids and their health benefit as well as 
metabolism, conversion in vivo especially in duck model 
 Introduction to omega-3 PUFAs 
Fatty acids with more than one double bond are classified as polyunsaturated fatty acids 
(PUFAs). Omega-3 PUFAs are fatty acids that have a double bond at the third position from the 
methyl end of carbon chain (Figure 1-10). There are two types of omega-3 PUFAs, known by 
short-chain omega-3 PUFAs which have less than 20 carbons such as -linolenic acid (ALA, 
C18:3n-3) and long-chain omega-3 PUFAs which have more than or equal to 20 carbons such as 
eicosapentaenoic acid (EPA, C20:5n-3) and docosahexaenoic acid (DHA, C22:6n-3). Other 
naturally occurring omega-3 PUFAs including stearidonic acid (C18:4n-3), eicosatrienoic acid 
(C20:3n-3), eicosapentaenoic acid (C20:4n-3), docosapentaenoic acid (C22:5n-3), etc. 
Our diet contains a complex mixture of fats and oils whose basic structural components are 
fatty acids. Omega-3 PUFAs generally account for a small fraction of the total daily consumption 
of fatty acids in Western societies.72 Usually, short-chain omega-3 PUFAs are presented in plant 
seeds and oil (such as canola oil, flaxseed oil, soybean oil, walnut oil, etc.), green leafy vegetables, 
and nuts and beans (such as walnuts and soybeans), while long-chain omega-3 PUFAs are found 
in marine products such as fish and algae. ALA is the major n-3 PUFA in the diet, with daily mean 
intakes estimated to be 1.6 g and 1.1 g per day for men and women, respectively72; while EPA and 
DHA intakes are estimated to be between 100–200 mg/d in the United States73. 
Omega-3 PUFAs must be obtained from diet, because humans do not have the enzymatic 
machinery required to synthesize omega-3 PUFAs, which makes them essential74. Through an 
inefficient enzymatic process of desaturation, ALA produce Arachidonic acid, precursors to a 
group of eicosanoids (prostaglandins, thromboxanes, and leukotrienes) that are anti-inflammatory, 
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antithrombotic, antiarrhythmic and vasodilatory.75 Compelling data from epidemiological and 
interventional studies demonstrated that it is long-chain but not short-chain omega-3 PUFAs have 
inverse correlation with the risk of some chronic disease.76–84 Thus, the 2015 Dietary Guidelines 
for Americans recommends the consumption of 8 oz. of seafood per week to provide an average 
of 250 mg/day of long-chain omega-3 fatty acids for health benefits85. Moreover, The American 
Heart Association’s Strategic Impact Goal Through 2020 and Beyond recommends at least two 
servings with 3.5 oz. fish every week to increase EPA and DHA intakes86. 
 Health benefit of long-chain omega-3 PUFAs 
It has been reported that long-chain but not short-chain omega-3 PUFAs possess the 
physiological properties of regulating blood pressure87, platelet reactivity and thrombosis88, 
plasma TG concentrations89, vascular function90, cardiac arrhythmias91, heart rate variability91, and 
inflammation92. These physiological properties are associated with some chronic diseases such as 
cardiovascular disease (CVD)76,77, psoriasis80, mental illnesses81, type-2 diabetes, cancers82,83, 
asthma84 etc. Several studies also revealed that in those chronic conditions, essential fatty acids 
metabolism is abnormal such that plasma and tissue concentrations of arachidonic acid (AA), EPA 
and DHA in the phospholipid fraction are low.93–96 
Given to a long history of studying cancer prevention, our lab has special interest in the 
mechanism of dietary compounds in preventing cancer. Increasing evidence from animal and in 
vitro studies indicates that omega-3 PUFAs, especially their long-chain members such as EPA and 
DHA could inhibit carcinogenesis.97 Several molecular mechanisms whereby omega-3 PUFAs 
potentially affect carcinogenesis have been proposed. These mechanism include: (1) suppression 
of AA derived eicosanoid biosynthesis, which results in altered immune response to cancer cells 
and modulation of inflammation, cell proliferation, apoptosis, metastasis, and angiogenesis; (2) 
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influences on transcription factor activity, gene expression, and signal transduction, which leads 
to changes in metabolism, cell growth, and differentiation; (3) alteration of estrogen metabolism, 
which leads to reduced estrogen-stimulated cell growth; (4) increased or de- creased production of 
free radicals and reactive oxygen species; and (5) mechanisms involving insulin sensitivity and 
membrane fluidity. However, the epidemiological studies on the association between long-chain 
omega-3 PUFAs intake and cancer risk remains controversial.98,99 The possible causes of the 
absence of an association between dietary long-chain omega-3 PUFAs and cancer risk in some 
epidemiological studies may falls into two aspects: (1) possible beneficial effect of marine omega-
3 PUFAs may be offset by potential carcinogenic substances, such as some pesticides and heavy 
metals (e.g., mercury), that accumulate in fatty fish.100 Furthermore, heterocyclic amines formed 
during the cooking of fish at high temperatures have been shown to produce cancer in various 
organs in animals101 (2) the discrepancy between animal and epidemiologic studies involves 
differences in doses and the stage of tumor development. In animal studies, large doses of omega-
3 PUFAs were usually used, and tumors were artificially induced. High doses of omega-3 PUFAs 
applied during the promotion and progression stages of tumor development may indeed inhibit 
carcinogenesis in animal models, whereas long-term exposures to relatively low doses of long-
chain omega-3 PUFAs may not be as effective against cancer development in humans. 
Metabolism of omega-3 fatty acids 
While mammals cannot synthesize omega-3 PUFAs de novo, mammalian cells can 
interconvert omega-3 PUFAs within each series by elongation, desaturation, and 
retroconversion.102 The simplest omega-3 PUFA, -linolenic acid (ALA, 18:3n-3), is 
synthesized from linoleic acid (LA, 18:2n-6) by desaturation, catalyzed by -15 desaturase in 
plants. Animals, including humans, do not possess the -15 desaturase enzyme and so cannot 
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synthesize ALA. Thus, ALA is a classically essential fatty acid, along with LA.  
Interconversion of omega-3 PUFAs 
After ingestion, ALA is converted to EPA, occurring primarily in the endoplasmic 
reticulum of liver cells and involves a series of elongation enzymes that sequentially add 2-carbon 
units to the fatty acid backbone and desaturation enzymes that insert double bonds into the 
molecules (Figure 1-2). EPA is elongated to docosapentaenoic acid (DPA) by elongase, the final 
step from DPA converting to DHA is controversial, there’re two possible pathways: (1) The Δ4 
pathway: DPA may be converted to DHA by Δ-4 desaturase103 however, the existence of Δ-4 
desaturation in the biosynthesis of DHA had been questioned for years, until a Δ-4 fatty acid 
desaturase was characterized in vegetative organisms.104 Nevertheless, the existence of such 
conversion for DHA synthesis in mammals is still unclear; (2) The Sprecher pathway: DPA is 
elongated to tetracosahexaenoic acid (THA) and translocation to peroxisomes, a 2-carbon removal 
by β-oxidation, and translocation of DHA back to the endoplasic reticulum.105  
The conversion from short-chain ALA to long-chain EPA and DHA 
ALA from plant oils is a metabolic precursor of the long-chain omega-3 PUFAs found in 
fish and fish oil, but the conversion is not efficient in humans, usually below 5% in adults106 or 
even less than 1% in infants and aging people107. This is because: (1) humans are lacking the key 
enzyme required to convert short-chain ALA to long-chain EPA and DHA; (2) the background 
diet may also have a significant impact on the conversion from ALA to DHA since the same 
enzymes are involved in omega-3 and -6 pathways; (3) EPA and DHA themselves may 
downregulating the conversion of ALA to long-chain PUFAs.  
Several investigators have performed detailed studies of the in vivo conversion of ALA to 
its long-chain omega-3 derivatives EPA, DPA and DHA in humans by using uniformly labeled 
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[13C]- or [2H] ALA as a tracer.106,108 These studies have consistently shown that over 15-35% of 
dietary ALA is rapidly catabolized to carbon dioxide for energy,109–112 and that only a small 
proportion, estimated by using compartment models to be less than 1% is converted to DHA.113 
The fractional conversion of ALA to EPA, estimated by measuring peak or area under the curve 
plasma contents of the labeled fatty acids, varies between 0.3% and 8% in men, and the conversion 
of ALA to DHA is  4% and often undetectable in males.110,112,114 Conversion of ALA to long-chain 
omega-3 fatty acids appears to be more efficient in women: up to 21% is converted to EPA and up 
to 9% is converted to DHA111, with a concomitant reduction in the rate of ALA oxidation ( 22% 
compared with  33% in men).110–112  
Background diet may have a significant impact the conversion from ALA to EPA and DHA. 
Diets high in LA may influence the metabolism of the omega-3 fatty acids through substrate 
competition and inhibition of Δ6 desaturase enzyme. Emken et al115 showed that a diet high in LA 
reduces the conversion of ALA to its long-chain derivatives by 40%, with a net reduction in long- 
chain n 3 fatty acid accumulation of 70%. Diets high in ALA appear to increase the rate of ALA 
oxidation, limiting its accumulation in plasma and reducing its conversion rate to EPA and 
DHA.109 
The conversion of DPA to DHA is the rate-limiting step in the conversion of ALA to DHA, 
and dietary DHA and EPA down-regulate this step by 70%.116 It is also reported that dietary EPA 
and DHA reduce the conversion of ALA to long-chain omega-3 fatty acids.109,110 DHA itself can 
serves as a substrate for metabolic retro-conversion to EPA and DPA through a β-oxidation 
reaction. In studies in which 13C-labeled DHA was fed, Brossard et al117 calculated the retro-
conversion rate of DHA to EPA in humans receiving normal dietary amounts of DHA to be 1.4%. 
Human clinical data have suggested rates as high as 12% with high chronic DHA 
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consumption.118,119 Retro-conversion of DHA to EPA is hormonally regulated and decreases in 
women receiving hormone replacement therapy.120 
 Omega-3 PUFAs in animal models 
In a typical Western diet, over 53% of dietary fat is supplied through animal products. 
As mentioned above, long-chain omega-3 PUFAs possess the potential health benefits to lower 
the risk of some chronic diseases, but there’s still nutritional gap between the recommended and 
actual consumption levels of EPA and DHA121. Therefore, feeding strategies have been adopted 
to increase the content of omega-3 fatty acids in animal food lipids like meat, eggs and milk.122–
124 
It has been noted that supplemented diets with vegetable oil and fish oil effectively 
enhanced omega-3 PUFAs in the products of pork,125 broilers,126,127 and broiler eggs128,129. Haak125 
reported that linseed and fish oil supplementation could enhance the incorporation of omega-3 
PUFAs in pork meat and also alter its fatty acid composition. Creps126 determined the effect of 
different dietary fatty acid profiles on nutrient and fatty acid balance in broiler chickens and found 
that chickens fed with linseed oil diet have higher amount of EPA and DHA in total body fat of 
chickens than other diets including tallow diet, olive oil diet and sunflower oil diet. This is in 
accordance with Lopez-Ferrer’s127 findings that supplemented linseed oil or fish oil in diet could 
significantly increase omega-3 PUFAs in chicken meat. Other animal product were also 
investigated, for example, Lemahieu’s128 and Antruejo129 found that feed supplemented with 
omega-3 PUFAs resulted in increased levels of these fatty acids in chicken product such as eggs.  
Although there’re many studies investigated animal models including pigs and chickens, 
there’s limited research on using duck as a model to assess the effect of dietary fats on fatty acid 
profile in duck products.  
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 Omega-3 PUFAs in duck model 
When compared with humans, waterfowls such as duck and geese have been reported to 
convert short-chain to long-chain omega-3 fatty acids more efficiently by a series of linked 
desaturation and elongation reactions that mainly take place in the liver130 and subsequently 
excreted into blood circulation to other tissues.131 The diverse conversion rates between human 
and waterfowl have driven scientists to consider that waterfowls may provide an alternate and 
sustainable source of long-chain omega-3 PUFAs from plant-derived short-chain ALA.132,133 
Ducks are aquatic birds which have a high rate of lipogenesis to meet their energetic 
requirements during ancient migratory flight.134,135 It has been reported, for instance, the percent 
body fat could be reached as high as 37–42% in Peking ducks and 20–30% in Muscovy ducks.136 
Although duck products are popular with its unique flavor and juicy texture, the high fat content 
has raised health concerns. While certain species of lean ducks, such as the Shan Partridge contains 
7.5% of body fat only have been developed, modification of the fat composition in favor of higher 
omega-3 PUFAs in replace of omega-6 PUFAs and/or saturated fatty acids (SFAs) may provide 
promising healthy benefits. Chen and Hsu137 reported an increased trend of EPA, DHA, and total 
omega-3 PUFAs in duck egg yolks by feeding cod liver oil diet. Our previous study found that fish 
oil and sunflower oil could significantly enhance the levels of EPA and DHA in the leg and chest 
muscles as well as eggs of Shan Partridge duck.137 
In addition to storage and transportation of lipids, liver of birds has a very high capacity of 
lipogenesis.138 Fatty acids can be synthesis or converted in the liver, and then transported to other 
tissues such as adipose, cardiac, and skeletal muscle. The conversion of fatty acids in the liver and 
incorporation of them into various tissues are well-established in response to the observed change 
of fatty acid composition in the relative tissues.139 Therefore, fatty acid conversion in the liver may 
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provide impact not only on a varied fatty acid composition but also on the meat quality including 
flavor and muscle color.140 From an aspect of nutrition value, efficient conversion efficient 
conversion of short- to long-chain omega-3 PUFAs in the liver may boost the levels of long-chain 
omega-3 PUFAs and thus improve the meat quality.  
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Figure 1-1 Structure of flavonoids, phenolic acids and tannins.1 
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Figure 1-2 Structures of stilbene and lignan.1 
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Figure 1-3 Diagram of sorghum caryopsis showing the pericarp [cutin, epicarp, mesocarp, 
tube cells, cross cells, testa, pedicel, and stylar area (SA)], endosperm (E) (aleurone layer, 
corneous, and floury), and germ [scutellum (S) and embryonic axis (EA)].141 
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Figure 1-4 Structures of simple phenols and phenolic acids found in sorghum.9,10,14 
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Figure 1-5 Structure of some sorghum flavanols.14 
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Figure 1-6  The main sorghum anthocyanidins and 3-deoxyanthocyanidin.14,21 
 
  
  43 
Figure 1-7 Structure of condensed tannins in sorghum.7,14 
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Figure 1-8 Levels of different cyclins in different cell cycle phases and regulation of 
different cell cycle phases by different cyclin-CDK complexes.46 
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Figure 1-9 Schematic diagram showing targets of same natural phenolic compounds in part 
of cell cycle regulatory network.46 
Red arrowhead or lines indicate activation or increasing of expression and green ones indicate 
inhibition or decreasing of expression. Quadrangular boxes contain phenolic compounds and 
round boxes contain components involving in cell cycle regulation.  
 
 
 
 
 
 
  
  46 
Figure 1-10 Structure of representative omega-3 PUFAs. 
(source: http://chemistry.tutorvista.com/biochemistry/omega-3-fatty-acids.html) 
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Figure 1-11 Conversion from ALA to EPA and DHA. ALA is converted to EPA through a 
sequential action of Δ-6 fatty acid desaturase, elongase, and Δ-5 desaturase. 
Note: EPA may be elongated to docosapentaenoic acid (DPA) and then desaturated by Δ-4 
desaturase to DHA. However, Sprecher et al.105 have demonstrated that EPA is likely elongated to 
DPA and to tetracosapentaenoic acid (TPA), desaturated to tetracosahexaenoic acid (THA) by Δ-
6 desaturase, translocated to peroxisomes, and β-oxidized to DHA. 
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Chapter 2 - Sorghum phenolic compounds are associated with cell 
growth inhibition through cell cycle arrest and apoptosis induction 
in human hepatocarcinoma HepG2 and colorectal adenocarcinoma 
Caco-2 cells 
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 Abstract 
Phenolic agents in sorghum have been associated with cancer prevention. However, direct 
evidence and the underlying mechanisms are mostly unknown. In this study, we selected 13 
phenolic-enriched sorghum accessions and tested their cell growth inhibition in the 
hepatocarcinoma HepG2 and colorectal adenocarcinoma Caco-2 cell lines. Total phenolic 
contents, as determined by Folin-Ciocalteu, were 30-64 mg GAE/g DW for the phenolic extracts 
of various accessions with comparison of the control accession F10000 at 2 mg GAE/g DW. 
Treatment of HepG2 with the extracted phenolics at 0-200 M GAE up to 72 hrs resulted in a 
dose- and time-dependent reduction in cell number. The IC50 values were varied from 85 to 221 
mg DW/mL when compared with the control F10000 at 1,275 mg DW/mL. The underlying 
mechanism was further examined in top two potential accessions (PI329694 and PI570481), 
significant inverse correlations were observed between the decreased cell number and increased 
cell cycle arrest at G2/M or induced cell death in both HepG2 and Caco-2 cells. The cytotoxic 
assay showed the sorghum phenolic extracts were non-toxic to the cells. The cytotoxic assay 
showed that the sorghum phenolic extracts were non-toxic. Although it was less sensitive, a similar 
inhibitory impact on cell growth and underlying mechanisms were found in colorectal 
adenocarcinoma Caco-2 cells. Taken together, these results indicated for the first time that a direct 
inhibition of either HepG2 or Caco-2 cell growth by phenolic extracts from the selected 13 
sorghum accessions. These findings also suggested that sorghum could be a valuable functional 
food by providing sustainable phenolics for potential cancer prevention.  
Keywords:  sorghum, phenolic compounds, cell growth inhibition, cell cycle analysis, apoptosis, 
HepG2, Caco-2
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 1. Introduction 
For many decades, the nutrition value of sorghum has considered to be less comparable with other 
cereals [1], even nowadays people still under-estimate the nutritional advantages of sorghum. In 
addition to gluten-free and suitable food for people with celiac disease, sorghum recently becomes 
of particular interests because of its high level and diversity of phenolics for potential health 
benefit, especially in cancer prevention [2]. Earlier investigation showed that an average of 35% 
of overall human cancer-related mortality was attributed to diet. [3] As a major component of 
healthy diets as well as the main bioactive compounds of sorghum, phenolic compounds are found 
rich in some sorghum accessions, whose profile is more diverse and higher than other crops such 
as wheat, barley, rice, maize, rye and oats. [4]  Numerous studies reported cancer prevention effect 
of phenolic compounds in fruits and vegetables while few was focused on that of sorghum whole 
grain. [1,5] 
           Compelling data from epidemiological and animal studies have suggested that phenolic 
compounds could potentially contribute to anti-cancer effect through their biological properties 
including antioxidant activity, induction of cell cycle arrest and apoptosis, and promotion of tumor 
suppressor proteins, etc. [8-10] There’re plenty of literature available on properties of various 
phenolic-rich foods such as tea and red wine/grapes in relation to various types of cancer[5], while 
studies regarding the association between sorghum phenolic compounds and cancers are scarce. 
Epidemiological studies reported that sorghum consumption consistently correlated with low 
incidences of esophageal cancer in various parts of the world (including several parts of Africa, 
Russia, India, China, Iran, etc.) whereas wheat and corn consumption correlated with elevated 
incidences. [9–11] In vivo studies regarding sorghum phenolics’ anti-cancer effect are even less, 
Lewis et al [12] in 2008 reported that by feeding normolipidemic rats with diet containing sorghum 
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bran could significantly reduce the number of aberrant crypts in the rats. More recently, Park et al 
[13] found that the metastasis of breast cancer to the lungs was blocked by sorghum extracts in the 
metastatic animal model. However, the mechanisms by which sorghum reduced the risk of cancer 
are unclear. In vitro data is the first and necessary step to understand the underlying mechanisms 
of anti-cancer effect. A few in vitro studies published recently using sorghum extracts to treat 
several cancer cells including leukemia (HL-60)[14], breast (MCF-7, MDA-MB 231) [15-16], 
colon (HT-29) [16] and liver (HepG2) [16] cells and found consistent results such as induction of 
cell apoptosis, inhibition of cell proliferation, and promotion of expression of cell cycle regulators 
by sorghum extracts.  
         In our study, the human hepatocellular carcinoma HepG2 cells were selected since liver is 
the major site for the metabolism of dietary compounds including phenolic compounds. However, 
to use only one cell line seems not sufficient enough to get a comprehensive understanding of the 
anti-cancer effect of sorghum phenolics. Given the reason that intestine is the major site for the 
absorption of phenolic compounds, and colorectal cancer appears most relevant to dietary factors 
when comparing with other type of cancers, we also selected the colon adenocarcinoma Caco-2 
cells, which is widely used as a valuable model for evaluation of anti-cancer effect of these 
compounds. Thus, our present study is the first time to use both HepG2 and Caco-2 cell lines for 
the effect on cell growth inhibition of sorghum phenolic extracts and meanwhile compare the 
underlying mechanisms including cell cycle arrest, apoptosis and cytotoxicity for both cell lines. 
         Given the high beneficial potential of sorghum phenolic compounds and the lag behind 
similar research on other plant foods, sorghum is a candidate food that deserves systematic 
investigation. Therefore, present study selected 13 sorghum accessions with high antioxidant 
activities tested by our previous studies, and was aimed to investigate: (1) the effect of extracted 
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sorghum phenolics on inhibiting cancer cell growth using HepG2 and Caco-2 cell lines; (2) and 
the underlying mechanisms regarding cytotoxicity and cell cycle interruption. The comparison 
between the two cell lines would contribute to a better understanding of anti-cancer activities by 
sorghum phenolics with a long-term goal to promote sorghum as a sustainable phenolics source as 
well as a healthy food product for humans in the western world. 
 
2. Materials and methods 
2.1. Sorghum accessions  
        Thirteen sorghum accessions that selected from previous studies as having high antioxidant 
activity were provided by Dr. Thomas Herald at USDA-ARS in Manhattan, KS. Accession 
numbers: PI152653, PI152687, PI193073, PI329694, PI559733, PI559855, PI568282, PI570366, 
PI570481, PI570484, PI570819, PI570889, PI570993. Another sorghum accession F1000 was 
selected as control as it has the least level of phenolics, while PI329694 and PI570481 together 
with the control were selected as representative sorghum accessions for the following assays in 
this study.  
2.2. Reagents 
        Reagents including acetone, ethanol, Folin-Ciocalteu reagent, gallic acid, sodium carbonate, 
HyClone Dulbecco’s Modified Eagle Medium (DMEM), fetal bovine serum, phosphate buffered 
saline (PBS), penicillin/streptomycin, trypsin-EDTA, propidium iodide (PI), RNase were 
purchased from Fisher Scientific Co. L.L.C (Pittsburgh, PA, 15275 USA). CytoSelectTM LDH 
Cytotoxicity Assay Kit was purchased from Cell Biolabs, Inc (San Diego, CA, 92126 USA). 
2.3. Extraction  
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        Sorghum flour (0.2-0.5g) were extracted in 10 mL 70% aqueous acetone (v/v) for 2 h while 
shaking at low speed using a 211DS shaking incubator (Labnet International, Inc., Edison, NJ 
USA), followed by storing at -20 °C in the dark overnight, allowing the phenolics to completely 
diffuse from the cellular matrix into the solvent and enhance extraction. Extracts were then 
equilibrated at room temperature, then centrifuged at 2970 × g for 10 min. The residue was rinsed 
with additional 10 mL solvents with 5 min shaking and centrifuged at 2970 × g for 10 min. The 
combined two aliquots were either used for total phenolic content determination or dried under a 
stream of Nitrogen followed by evaporation. The dried extracts were then dissolved in dimethyl 
sulfoxide (DMSO) to make stock solutions and stored at -20 °C for further analysis. Before each 
use, the stock solution was diluted with fresh medium to achieve the desired concentrations (0-200 
M GAE). The final DMSO concentration in all cultures was <0.1%,  which did not alter cell 
growth and cell cycle measurements when compared with vehicle-free medium. All extractions 
and analysis were conducted in triplicate. 
2.4. Total phenolic content 
        Determination of total phenolic contents was performed using the Folin-Ciocalteu assay [17], 
adapted to 96-well microplates. A stock solution of 1 mg/mL Gallic acid in distilled water was 
prepared, and concentrations ranging from 12.5-200 g/mL in 70% acetone were made for a 
standard curve. A solution of Na2CO3 at 7.5% (w/v) was also prepared. To each of the 96 wells, 
75 L distilled water was added, followed by 25 L either aliquot of extracts or gallic acid standard 
at various concentrations. Folin-Ciocalteu reagent diluted 1:1 with distilled water was then added 
to each well. The reaction was allowed to stand for 10 min at room temperature, and then 100 L 
of Na2CO3 solution was added to each well. Plate was covered and stand in dark for 90 min before 
measuring. Absorbance were read in a microplate reader SynergyHT, Biotek (Winnoski, USA); 
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with Gen5TM2.0 data analysis software. Results were expressed as mg gallic acid equivalent (GAE) 
per g dry weight (DW). 
2.5. Cell culture 
        The human hepatocellular carcinoma cells HepG2 (HB-8065) and human colorectal 
adenocarcinoma cells Caco-2 (HTB-37) were purchased from American Type Culture Collection 
(ATCC), Manassas, VA, 20108 USA. Cells were cultured in DMEM supplemented by 10% FBS, 
100 g/mL streptomycin, and 100 units/mL penicillin at 37 °C in a 5% CO2 humidified 
atmosphere. Cells in the exponential growth phase were used for all experiments. 
2.6. Cell growth inhibition assay 
        Two milliliter cell suspension (1  105 cells/mL) were seeded into 6-well plates and cultured 
in a humidified incubator to allow adhesion. Cells were then treated with extracted sorghum 
phenolics at various concentrations of 0-200 M GAE for up to 72 hrs. After incubation with each 
treatment, cells at 24, 48 and 72 hrs were detached by 0.05% trypsin-EDTA solution at 37 °C and 
then suspended in PBS. The number of suspended cells was counted with a hemacytometer as 
described by our previous publication.[18] IC50 values for each accession at 72 hrs were calculated 
based on the cell growth inhibition data.  
2.7. Cytotoxicity assay 
        Cytotoxicity was assessed by lactate dehydrogenase (LDH) leakage into the culture medium. 
The activity of LDH in the medium was determined using a commercially available kit 
CytoSelectTM LDH Cytotoxicity Assay Kit from Cell Biolabs, Inc. Cell suspension containing 0.1-
1.0  106 cells/mL were seeded into a 96-well plate and cultured at 37°C and 5% CO2 with sorghum 
extracts at 0-200 M GAE for 24 hours. Negative (sterile water) control was then added to each 
well and positive (Trition X-100) control were added to wells without sorghum extracts at the same 
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time. Aliquots of media and reagents were mixed in a 96-well plate and incubated at 37 °C and 
5% CO2 for 0.5 hrs. Absorbance was recorded using a microplate reader SynergyHT, Biotek 
(Winnoski, USA), and analyzed with Gen5TM2.0 data analysis software. The % Relative 
Cytotoxicity was calculated using the following equation: 
𝑂𝐷(𝑒𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡 𝑠𝑎𝑚𝑝𝑙𝑒)−𝑂𝐷(𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒 𝑐𝑜𝑛𝑡𝑟𝑜𝑙)
𝑂𝐷(𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝑐𝑜𝑛𝑡𝑟𝑜𝑙)−𝑂𝐷(𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒 𝑐𝑜𝑛𝑡𝑟𝑜𝑙)
   100 = % Relative Cytotoxicity 
2.8. Cell cycle analysis 
        The cell cycle analysis was conducted for sorghum accession PI329694 as having highest 
total phenolic content (Table 1), and PI570481 as having lowest IC50 value (Table 2), as well as 
the sample control F10000. Cells were treated with extracted sorghum phenolics at various 
concentrations (0-200 M GAE) and harvested after 72 hrs. After centrifugation, cells were fixed 
in 70% ethanol at 4 °C and then re-suspended in propidium iodide (PI) staining solution containing 
20 g/mL PI and 5 U/mL RNase in PBS at 37 °C for 15 min before analysis by a flow cytometry 
(LSR Fortessa X-20 and FACSCalibur, BD, Franklin Lakes, NJ 07417-1880 USA) with excitation 
at 488 nm and emission at 617 nm. 
2.9. Statistics 
        Data were analyzed by the SAS statistical system (version 9.2). The significance of the trend 
for cell growth inhibition at various concentrations for three exposure times was analyzed with 
linear regression. The effect of extracted phenolic at various concentrations for 72 hours on cell 
cycle arrest and apoptosis was analyzed by one-way ANOVA with Tukey adjustment. Pearson 
correlation coefficients (r) were used to analyze the relationships between total phenlic contents 
and IC50 values for all sorghum accessions, as well as cell numbers and percentages of cells arrest 
at G2/M or apoptosis for accession PI329694, PI570481 and control for both cell lines. 
 
  69 
3. Result 
3.1. Total phenolic content 
        The total phenolic contents for the 13 sorghum accessions were determined by Folin-
Ciocalteu method as described previously, results were expressed as mg gallic acid equivalent per 
g dry weight (GAE/g DW). The total phenolic contents ranged from 31 to 63.7 mg GAE/g DW 
with the highest being PI329694, while the control (F10000) was as low as 2.3 mg GAE/g DW 
(Table 1).  
3.2. Cell growth inhibition 
        The cell growth inhibition assay was conducted for all accessions in HepG2 cells (Figure 1), 
IC50 values (table 2) were calculated for each accession by linear regression of cell growth 
inhibition data at 72 hours. Results showed a dose-dependent decrease in cell numbers for all the 
accessions in HepG2 cell. Although the cell growth inhibition patterns were similar among the 13 
sorghum accessions examined in our study. However, IC50 values (table 2) varied from 85.8 to 
221.8 mg DW/mL comparing with the control that has an IC50 value as high as 1275.6 mg DW/mL. 
The IC50 value for accessions PI570481 was the lowest which suggested that PI570481 was the 
most efficient in suppressing HepG2 cells growth. Based on the result of total phenolic content 
and IC50 values, PI329694, PI570481, and the control (F10000) were selected for Caco-2 cells and 
comparing with the result in HepG2 cells. Results as shown in figure 2 indicated that treatment of 
both cell lines with sorghum phenolic extracts at 0 to 200 M GAE for up to 72 hours resulted in 
a dose- and time- dependent reduction in cell number. The IC50 values were calculated at 72 hours 
for the three representative accessions in both cell line, PI329694 had a lowest value (102.4 mg 
DW/mL) in Caco-2 cells while PI570481 (85.8 mg DW/mL) being the lowest in HepG2 cells. The 
IC50 values of F10000 in both cell lines were around 10 times higher than the other two accessions. 
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3.3. Cytotoxicity assay 
        Cytotoxicity was tested in both cell lines, and assessed by lactate dehydrogenase (LDH) 
leakage into the culture medium using a commercially available kit CytoSelectTM LDH 
Cytotoxicity Assay Kit from Cell Biolabs, Inc. The % Relative Cytotoxicity values at each 
concentrations of sorghum extracts for various sorghum accessions were calculated using the 
equations mentioned previously, all the values were lower than 15% and the treated cells did not 
differ significantly from the vehicle control, which suggested that sorghum phenolic extracts were 
non-toxic to both cell lines (data not shown). 
3.4. Cell cycle arrest and cell death 
        Sorghum accession PI329694, PI570481 and F10000 was selected as representative for cell 
cycle analysis. The effect of sorghum phenolic extracts on cell cycle was assessed by using a DNA 
flow cytometry, results were shown in Figure 3. Treatment of HepG2 with sorghum phenolic 
extracts at 0-200 M GAE for 72 hours showed an increase in the percentage of cells at G2/M 
phase and a decrease in the percentage of cells at G1 phase. While in Caco-2 cells, it did not show 
an increase in G2/M phase or decrease in G0/G1 phase until phenolic concentration reached 100 
M GAE. Proportions of cells at S-phase were not significantly altered by sorghum phenolic 
extracts at any concentration in the two cell lines. The treatment of HepG2 with sorghum phenolic 
extracts at 0-200 M GAE for 72 hours also resulted in an increase in the percentage of dead cells 
in both cell lines for the three accessions (Figure 4).  
 
3.5. Correlation coefficient 
        Correlation coefficient (r) was calculated to determine whether an association existed 
between: (1) total phenolic contents and IC50 values from 13 sorghum accessions in HepG2 cells; 
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(2) cell number decreasing and accumulation % of cells at G2/M phase or dead cells for accessions 
PI329694, PI570481 and control in both cell lines. As shown in Table 3, significant inverse 
correlation was observed between total phenolic contents and IC50 values in all accessions (r = -
0.6806, p<0.05). Meanwhile significant inverse correlations (Table 3) were also observed between 
the decreasing of cell number and increasing accumulation of G2/M and dead cells in sorghum 
accessions PI 329694, PI570481and control in both HepG2 and Caco-2 cells.  
 
 4. Discussion  
        Thirteen sorghum accessions were selected from previous studies as having high antioxidant 
activity, accession F10000 that having the least phenolic content was selected to serve as control. 
Phenolic compounds could be classified as antioxidants because of their phenol rings and hydroxyl 
groups in the structure. In the present study, total phenolic contents determined by Folin-Ciocalteu 
assay were 30-64 mg GAE/g DW in various accessions (Table 1) while the control only contains 
2.3  0.2 mg GAE/g DW total phnoelics. This result indicate that the thirteen accessions could be 
potential candidates of phenolic resource for cancer prevention because higher phenolic content 
are potentially linked to higher antioxidant activity. Antioxidants are reported having the potential 
ability to prevent the initiation of carcinogenesis via either direct scavenging of reactive 
oxygen/nitrogen species (ROS/RNS) or induce cellular defense detoxifying/antioxidant enzymes 
that contribute to cellular protection against ROS/RNS and reactive metabolites of 
carcinogens.[19]  
Treatment of sorghum phenolics at various concentrations for up to 72 hours resulted in a 
significant inhibition of cell growth in a dose- and time- dependent manner (Figure 1 and 2) in 
both HepG2 and Caco-2 cell lines. The selected two cell lines which were derived from intestine 
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and liver respectively, are believed to have the opportunity of exposing to sorghum phenolic 
compounds after ingestion. IC50 values were calculated based on the data of cell number reduction 
at 72 hrs in cell growth inhibition assay and found to vary from 85.8 to 221.8 mg DW/mL (Table 
2), with sorghum accession PI570481 being the lowest and PI559855 the highest when comparing 
with that (1275.6 mg DW/mL) of control in HepG2 cells. Similar results also found in Caco-2 cells 
treated with various concentrations of phenolic extract from sorghum accession PI329694, 
PI570481 and control (Table 2 and Figure 2). These results indicated that sorghum accessions rich 
in phenolic compounds effectively suppressed the cell growth in both HepG2 and Caco-2 cell 
lines. Possible inhibition mechanisms including: (1) perturb cell cycle specific proteins, affect 
and/or block the continuous proliferation of tumorigenic cells[20]; (2) induce apoptosis by 
activation of caspases-3 and -9, diminished levels Bcl-2 and Mcl-1[21], [22], or cell cycle arrest,  
etc.  
To investigate the underlying mechanisms of cancer cell growth inhibition by sorghum 
phenolics, cytotoxicity was tested by using a commercial available kit, this assay is based on the 
conversion of lactate to pyruvate in the presence of LDH (Lactate Dehydrogenase) with parallel 
reduction of NAD. The formation of NADH from the above reaction results in converting WST-1 
(present in the reagent) to an orange formazan that can be detected under absorbance at 450 nm. 
The % Relative Cytotoxicity values at each concentrations of sorghum phenolic extracts for 
various sorghum accessions in both cell lines were lower than 15% and the treated cells did not 
differ significantly from the vehicle control, which suggested that sorghum phenolic extracts were 
non-toxic to the cells. However, we still found dead cells in cell cycle analysis by flow cytometry, 
the percentage of dead cells were increased in a dose-dependent manner in both cell lines (Figure 
4). In addition, both cell lines undergone accumulation of G2/M phase and decrease of percentage 
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of cells at G1 phase (Figure 3). These findings indicated that the death of the cells appears to be 
cytostatic, not cytotoxicity, since the cytotoxicity assay showed the sorghum phenolics are non-
toxic to the cells. To further confirm the cause of cell death, we could use tunnel assay or apoptosis 
marker such as annexin V. Cancer progression has been suggested to involve the loss of cell-cycle 
checkpoint controls that regulate the passage through the cell-cycle. These checkpoints monitor 
the integrity of the DNA and ensure that genes are expressed in a coordinated manner.[23] The 
cell cycle arrest may trigger the DNA repair machine, leading to apoptosis which causes cell death. 
The apoptosis in HepG2 and Caco-2 cells may also induced through changing mitochondrial 
membrane potential and downregulation of the anti-apoptotic protein, bcl(xl). [24] 
        Coefficient correlations were further calculated between (1) total phenolic contents and IC50 
values in the 13 accessions in HepG2 cells; (2) cell number decreasing and proportion of cells 
arrested at G2/M phase for the three representative accessions in both cell line; (3) cell number 
decreasing and proportion of dead cells for the three representative accessions in both cell line. 
Significant inverse correlation observed between total phenolic contents and IC50 values of the 
thirteen sorghum accessions (Table 3) suggested the cell growth inhibition by sorghum extracts 
was associated with their phenolic contents. While, strong significant inverse correlations observed 
between dose-dependent cell number decreasing and accumulation of cells in G2/M phase and 
dead cells (Table 3) in both cell lines, further suggested that the inhibitory effect of sorghum 
phenolic compounds on cell growth is through cytostatic. The higher r values of percentage of 
cells at G2/M phase in HepG2 cells may indicate that these cells were more sensitive to sorghum 
phenolic extracts than Caco-2 cells which may due to intrinsic properties of the cells.  
        In conclusion, the present study shows that phenolic extracts in sorghum effectively inhibited 
HepG2 or Caco-2 cell growth in a dose- and time- dependent manner. The cell growth inhibition 
  74 
by the sorghum extracts were significantly associated with their phenolic contents. Furthermore, 
the inhibition appeared to be mediated by cytostatic, not cytotoxicity. Taken together, this study is 
the first time to investigate and compare the anti-cancer effect of sorghum phenolic compounds in 
both HepG2 and Caco-2 cell lines, our findings suggested that sorghum is a valuable food crop to 
provide sustainable phenolics and furthermore promote human health. 
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Table 2-1 Phenolic Contents in Various Sorghum Accessions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                     Values are expressed as mean ± SD (n=3); mg GAE/g 
DW represent for milligram gallic acid equivalent per 
gram dry weight. 
   
Sorghum Accession 
No. 
Total Phenolic Content 
(mg GAE/g DW) 
F10000 (control) 2.3  0.2 
PI 559855 31.0  0.2 
PI 152687 44.6  2.9 
PI 570819 48.2  4.4 
PI 570993 51.0  1.9 
PI 559733 51.5  1.4 
PI 570366 54.3  1.7 
PI 152653 54.6  1.2 
PI 570484 54.8  0.8 
PI 193073 55.1  4.5 
PI 570889 58.0  2.0 
PI 568282 58.3  2.5 
PI 570481 58.5  2.5 
PI 329694 63.7  2.5 
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Table 2-2 IC50 Values of sorghum phenolic extracts in HepG2 and Caco-2 cells 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Sorghum Accession 
No. 
IC50 
(mg DW /mL) 
 HepG2 Caco-2 
F10000 (control) 1275.6 1131.3 
PI 559855 221.8  
PI 152687 138.9  
PI 570819 192.1  
PI 570993 146.2  
PI 559733 90.8  
PI 570366 120.9 / 
PI 152653 127.9  
PI 570484 158.0  
PI 193073 177.3  
PI 570889 120.9  
PI 568282 113.3  
PI 570481 85.8 115.6 
PI 329694 126.8 102.4 
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Table 2-3 Correlation coefficient (r) among total phenolic contents with IC50 values from 
the phenolic extracts of 13 sorghum accessions in HepG2 cells, or cell number with cell 
cycle arrest and apoptotic cells from control, PI329694 and PI570481 in both cell lines. 
 
IC50 
  
Total phenolic content -0.6806* 
  
  Cell Arrest  
at G2/M 
Apoptotic 
cells 
HepG2 
   
F10000 control  -0.8608* -0.9377** 
PI329694 Cell number -0.8281* -0.9764** 
PI570481  -0.9469** -0.9097** 
Caco-2    
F10000 control  -0.7599* -0.9719** 
PI329694 Cell number -0.7655* -0.8199* 
PI570481  -0.6840* -0.8925* 
      *p<0.05, **p<0.01.  
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Figure Legends 
Figure 2-1 The effect of various sorghum phenolic extracts at 0-200 M GAE on cell 
number in HepG2 cells after 72 hrs. HepG2 cells were cultured with phenolic extracts at 
various concentrations (0-200 M GAE) in 6-well plates, and then detached by trypsin-EDTA 
solution, and the cell number was counted by a hemacytometer. Values are expressed as Mean  
SD (n=3), the significance of the trend for cell growth inhibition at various concentrations was 
analyzed with linear regression, p<0.05. 
Figure 2-2 The effect of representative sorghum phenolic extracts at 0-200 M GAE on cell 
number in both HepG2 and Caco-2 cells for up to 72 hrs. The representative sorghum 
accessions were: PI329694, PI570481 and control (F10000). Cells were cultured with phenolic 
extracts at various concentrations (0-200 M GAE) in 6-well plates, then detached by trypsin-
EDTA solution and harvested by resuspension in medium for an immediate counting of cell 
numbers by hemacytometer at each time point. Values are expressed as Mean  SD (n=3), the 
significance of the trend for cell growth inhibition at various concentrations at each time point 
was analyzed with linear regression, p<0.05. 
Figure 2-3 Cytostatic effect of representative sorghum phenolic extracts in HepG2 and 
Caco-2 cell lines. The representative sorghum accessions were: PI329694, PI570481 and control 
(F10000). Cells were cultured with sorghum phenolic extracts at 0-200 M GAE for 72 hrs, and 
then cell cycle was monitored by a DNA flow cytometric analysis as follows: solid circles, % of 
cells at G1 phase; open circles, % of cells at G2/M phase; solid triangles, % of cells at S phase. 
Values are expressed as Mean  SD (n=3), *p<0.05, **p<0.01 versus the vehicle controls. 
Figure 2-4 Percentage of dead cells induced by representative sorghum phenolic extracts in 
HepG2 and Caco-2 cell lines. The representative sorghum accessions were: PI329694, 
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PI570481 and control (F10000). Cells were cultured with sorghum phenolic extracts at 0-200 
M GAE for 72 hrs, and then apoptosis was analyzed by a DNA flow cytometry. Values are 
expressed as Mean  SD (n=3), *p<0.05, **p<0.01 versus the vehicle controls. 
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Figure 2-1 The effect of various sorghum phenolic extracts at 0-200 μM GAE on cell 
number in HepG2 cells after 72 hrs. 
 
Values are expressed as Mean  SD (n=3), the significance of the trend for cell growth inhibition 
at various concentrations was analyzed with linear regression, p<0.05 
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Figure 2-2 The effect of representative sorghum phenolic extracts at 0-200 μM GAE on cell 
number in both HepG2 and Caco-2 cells for up to 72 hrs. 
 
 
 
Values are expressed as Mean  SD (n=3), the significance of the trend for cell growth inhibition 
at various concentrations at each time point was analyzed with linear regression, p<0.05.  
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Figure 2-3 Cytostatic effect of representative sorghum phenolic extracts in HepG2 and 
Caco-2 cell lines. 
 
 
 
Values are expressed as Mean  SD (n=3), *p<0.05, **p<0.01 versus the vehicle controls. 
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Figure 2-4 Percentage of dead cells induced by representative sorghum phenolic extracts in 
HepG2 and Caco-2 cell lines. 
 
 
 
Values are expressed as Mean  SD (n=3), *p<0.05, **p<0.01 versus the vehicle controls. 
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Chapter 3 - Effect of Various Dietary Fats on Fatty Acid Profile in 
Duck Liver: Efficient Conversion of Short-chain to Long-chain 
Omega-3 Fatty Acids 
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 Abstract 
Omega-3 fatty acids, especially long-chain omega-3 fatty acids, have been associated with 
potential health benefits for chronic disease prevention. Our previous studies found that dietary 
omega-3 fatty acids could accumulate in the meat and eggs in a duck model. This study was to 
reveal the effects of various dietary fats on fatty acid profile and conversion of omega-3 fatty acids 
in duck liver. Female Shan Partridge Ducks were randomly assigned to five dietary treatments, 
each consisting of 6 replicates of 30 birds. The experimental diets substituted the basal diet by 2% 
of flaxseed oil, rapeseed oil, beef tallow, or fish oil, respectively. In addition, a dose response study 
was further conducted for flaxseed and fish oil diets at 0.5%, 1%, and 2%, respectively. At the end 
of the 5-week treatment, fatty acids were extracted from the liver samples and analyzed by GC-
FID. As expected, the total omega-3 fatty acids and the ratio of total omega-3/omega-6 
significantly increased in both flaxseed and fish oil groups when compared with the control diet. 
No significant change of total saturated fatty acids or omega-3 fatty acids was found in both 
rapeseed and beef tallow groups. The dose-response study further indicated that 59-81% of the 
short-chain omega-3 ALA in flaxseed oil-fed group was efficiently converted to long-chain DHA 
in the duck liver, whereas 1% of dietary flaxseed oil could produce an equivalent level of DHA as 
0.5% of dietary fish oil. The more omega-3 fatty acids, the less omega-6 fatty acids in the duck 
liver. Taken together, this study showed the fatty acid profiling in the duck liver after various 
dietary fat consumption, provided insight into a dose response change of omega-3 fatty acids, 
indicated an efficient conversion of short- to long-chain omega-3 fatty acid, and suggested 
alternative long-chain omega-3 fatty acid-enriched duck products for human health benefits.    
Keywords: omega-3 fatty acid, duck, liver, dietary fat, health benefits  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 Introduction 
Omega-3 polyunsaturated fatty acids (ω-3 PUFAs), in addition as essential nutrients, have 
been associated with potential health benefits in chronic disease prevention. There are two types 
of ω-3 PUFAs, known by short-chain ω-3 PUFAs like ALA (alpha-linolenic   acids, C18:3n-3) 
or long-chain ω-3 PUFAs such as EPA (eicosapentaenoic acid, C20:5n-3) and DHA 
(docosahexaenoic acid, C22:6n-3). Short-chain ω-3 PUFAs are presented in plant oil such as 
flaxseed and soybean oil, while long-chain ω-3 PUFAs are usually found in marine products such 
as fish oil. Although short-chain ω-3 PUFAs are more common and less expensive, the potential 
health benefits of ω-3 PUFAs have been related to long-chain ω-3 PUFAs only.    
Compelling data from epidemiological and interventional studies have demonstrated an inverse 
correlation between long-chain ω -3 PUFAs and risk of some chronic diseases,   including 
cardiovascular diseases,1,2
 
myocardial infarction,3,4
 
psoriasis,5
 
mental illnesses,6
 
  cancer,7,8
 
and 
bronchial asthma.9
 
Although it is not conclusive, some clinical trials also found long-chain ω-3 
PUFAs contributed to a lower risk of cancers, such as colon,10,11
 
  breast,12,13 and prostate 
cancers.14
 
Therefore, the 2015 Dietary Guidelines for Americans recommends the consumption of 
8 oz. of seafood per week to provide an average of 250 mg/day of long chain omega-3 Fatty acids 
for health benefits.15
 
Moreover, The American Heart Association’s Strategic Impact Goal Through 
2020 and Beyond recommends at least two servings with 3.5-oz. fish every week to increase EPA 
and DHA intakes16, while an adequate intake of ω-6 linoleic acid as 17 g/d for men and 12 g/d for 
women at the age of 19 to 50 years17.  
 Humans can convert short-chain to long-chain omega-3 fatty acids, but the conversion 
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efficiency is limited, usually below 5% in adults18
 
or even less than 1% in infants and aging 
people.19
 
When compared with humans, however, waterfowls such as geese have been reported to 
convert short-chain to long-chain omega-3 fatty acids more efficiently by a series of desaturase 
and elongase in the liver20
 
and subsequently excreted into blood circulation to other tissues.21
 
The 
diverse conversion rates between human and waterfowl have driven scientists to consider that 
waterfowls may provide an alternate and sustainable source of long-chain ω-3 PUFAs from plant-
derived short-chain ALA.22-24
 
 
Ducks are aquatic birds which have a high rate of lipogenesis to meet their energetic 
requirements during ancient migratory flight.25-26
 
It has been reported, for instance, the percent 
body fat could be reached as high as 37-42% in Peking ducks and 20-30% in Muscovy ducks.27
 
Although duck products are popular with its unique flavor and juicy texture, the high fat content 
has raised health concerns. While certain species of lean ducks, such as the Shan Partridge contains 
7.5% of body fat only have been developed, modification of the fat composition in favor of higher 
ω-3 PUFAs in replace of ω-6 PUFAs and/or saturated fatty acids may provide promising healthy 
benefits. It has been noted that supplemented diets with vegetable oil and fish oil effectively 
enhanced ω-3 PUFAs in the products of pork,28 broilers29,30 and broiler eggs.31,32 Dietary ALA was 
also reported to promote EPA and DHA contents in chicken liver.33 Furthermore, Chen and Hsu 
reported an increased trend of EPA, DHA, and total ω-3 PUFAs in duck egg yolks by feeding cod 
liver oil diet.34 In addition to storage and transportation of lipids, liver of birds has a very high 
capacity of lipogenesis35. Fatty acids can be synthesis or converted in the liver, and then 
transported to other tissues such as adipose, cardiac and skeletal muscle. The conversion of fatty 
acids in the liver and incorporation of them into various tissues are well-established in response to 
the observed change of fatty acid composition36  in the relative tissues. Therefore, fatty acid 
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conversion in the liver may provide impact not only on a varied fatty acid composition but also on 
the meat quality including flavor and muscle color37. From an aspect of nutrition value, efficient 
conversion of short- to long-chain ω-3 PUFAs in the liver may boost the levels of long chain ω-3 
PUFAs and thus improve the meat quality. Our previous study found that fish oil and sunflower 
oil could significantly enhance the levels of EPA and DHA in the leg and chest muscles as well as 
eggs of Shan Partridge duck.38 However, the effect of various dietary fats on fatty acid profile and 
the conversion efficacy of ω-3 PUFAs in duck liver, to our knowledge, has yet to be well studied. 
The aim of this study was to assess the modification of fatty acid profiles in the liver of 
Shan Partridge duck after feeding various dietary fats, including ALA-enriched flaxseed oil, ω-6 
PUFA-enriched rapeseed oil, saturated fatty acid-enriched beef tallow, and EPA/DHA-enriched 
fish oil. The conversion efficacy of short-chain to long-chain ω-3 PUFAs was further investigated 
by a dose-response study for flaxseed and fish oil treatment, respectively.    
 
  Materials and methods 
   Animals 
Female Shan Partridge Ducks of the same genetic background and of comparable body    
weight at the age of 370 days were housed in the same room with incandescent lighting on 15:9 h 
light-dark cycle. Feed and water were provided for ad libitum consumption.  
Experimental design 
Shan Partridge Ducks were randomly assigned into 5 dietary treatment groups 
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including  a control group (each group with 6 replicates of 30 birds). The experimental diets 
substituted the basal diet by 2% of flaxseed oil, rapeseed oil, beef tallow, or fish oil, respectively. 
Control group was feed with the basal diet. In addition, a dose response  study was further 
conducted for flaxseed and fish oil diets only. Total 7 experimental  groups fed various 
substituted basal diet by 0.5%, 1%, and 2% flaxseed or fish oil respectively, and the control group 
fed with the basal diet. Each group had 6 replicates.  The ingredients and calculated nutrient level 
of the basal control diet was formulated to meet the nutrient requirements of the National Research 
Council (Table 1). The measured fatty acid values of the experimental diets in the present study is 
shown in Table 2. Diets were balanced to similar levels of protein, fat, total energy, and fiber. At 
the end of the 5-week dietary treatment, ducks were sacrificed and fresh duck livers were stored 
at -20°C for further lipid extraction.  
Lipid extraction 
One gram of the liver sample was grinded and mixed with 2 mL of chloroform/methanol 
(1:2, v/v in 0.001% Butylated hydroxytoluene), 1 mL of chloroform, and 1 mL of water. The 
mixture was then centrifuged at 1,000 rpm for 15 min. The lower layer was then collected. The 
above procedure was repeated twice. All the three lower layers were combined together and 
evaporated under a stream of N2 gas. One mL of chloroform was added to the dried tube before 
stored at -80°C until further lipid analysis.    
Fatty acid analysis 
Fatty acid methyl esters were synthesized according to the protocols of the Kansas 
Lipidomics Research Center. Briefly, each lipid extracted sample was transferred to Teflon-lined 
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screw cap tube. An internal standard, pentadecanoic acid (C15:0), was added to each sample. 
Derivatization was performed with 1mL of 3 M methanolic hydrochloric acid at 78°C for 30 min. 
Then 2 mL of water and 2 mL of hexan:chloroform (4:1, v/v) were added to each tube. The upper 
phase was collected after vortex and centrifuge. After the above procedure was repeated twice, 
three upper phase were combined and dried under nitrogen gas, re-dissolved in 200 μL of hexane 
and transferred into a GC vial with insert.  
Fatty acid methyl esters were analyzed using an Agilent 6890N gas chromatography 
equipped with a programmed temperature vaporization injector, an Agilent 7683 autosampler, and 
Agilent flame ionization detector (Santa Clara, CA). The GC was fitted with a HP-88 capillary 
column (100m × 0.25mm × 0.2μm, Agilent, Santa Clara, CA). The injector temperature was 
operated at 275°C with an injection volume of 1 μL. The detector temperature was set at 260°C. 
Helium was used as the carrier gas at a flow rate of 1.6 mL/min. The flow rate of air and hydrogen 
were 400 mL/min and 30 mL/min, respectively. The oven temperature ramp was programmed 
from an initial value of 150°C for 1 min to 175°C at 10°C /min for 10min, and then to 210°C at 
5°C/min for 5 min hold, finally to 230 °C at the same speed for 11 min. The total run time per 
sample is 40.5 min and the sampling rate of the FID was 20 Hz. Fatty acid peaks were identified 
by comparison of the relative retention times with the Supelco® 37 component fatty acid methyl 
ester mix standards. The content of each fatty acid was calculated based upon the area of each 
identified peak.  
Statistical analysis 
Data are expressed as mean ± SD. All the data were analyzed by two-way analysis of 
variance (ANOVA) and followed by pairwise comparison with Tukey adjustment using SAS 9.2 
(SAS Institute Inc., Cary, NC, USA). A value of P < 0.05 considered to be statistically significant.  
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 Results 
Fatty acid profile in duck liver  
A representative gas chromatography selected from each treatment group was showed in 
Figure 1. Total 23 fatty acids including the internal standard (peak 2, pentadecanoic acid, 15:0) 
were identified and analyzed in the duck liver samples, including saturated fatty acids (SFA 14:0, 
15:0, 16:0, 17:0, 18:0, 22:0, and 24:0), monounsaturated fatty acids (MUFA 16:1n-10, 16:1n-7, 
18:1n-9, 18:1n-7, and 20:1), ω-3 PUFAs (18:3, 18:4, 20:5, 22:5, and 22:6), and ω-6 PUFAs (18:2, 
20:2, 20:3, 20:4, 22:4, and 22:5). As shown in Table 3, the contents of fatty acids in duck liver fed 
various dietary fats for 5 weeks varied. No significant difference of total SFA, total MUFA, total 
ω-6 PUFAs, or individual ω-6 PUFA 18:2 and 20:2 was found among the treatment groups. Both 
short-chain ω-3 PUFA ALA (C18:3) and long-chain ω-3 PUFA DHA (C22:6) were significantly 
abundant in flaxseed oil group, while long-chain ω-3 PUFA DHA only were considerably found 
in fish oil group. The highest content of total ω-3 fatty acids was detected in fish oil-fed group, 
followed by flaxseed oil-fed and rapeseed oil-fed group. The content of arachidonic acid, one of 
the ω-6 PUFAs (20:4), was significantly lower in both flaxseed oil and fish oil groups when 
compared with the control. The ratios of total PUFA/SFA and Σn3/Σn6 were significantly higher 
in the flaxseed oil, rapeseed oil, and fish oil groups than that in the beef tallow or the control 
groups. 
A dose response study  
In order to investigate the conversion efficacy of short-chain to long-chain ω-3 fatty acids 
in the liver, a dose response study using flaxseed oil diet at 0.5%, 1%, and 2% doses versus fish 
oil diet was conducted. As shown in Table 4, the contents of ALA in the livers of ducks fed various 
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doses of flaxseed oil increased from the basal line of 0.06 to 0.16, 0.36, and 0.65 mg/g fresh weight 
gradually. Meanwhile, DHA content in flaxseed oil-fed group also increased from 0.29 to 0.72, 
1.06, and 1.01 mg/g fresh weight. In fish oil-fed groups, DHA but not EPA content increased 
significantly from 0.29 to 1.11, 1.76, and 2.08 mg/g fresh weight. On the contrary, the content of 
ω-6 arachidonic acid (AA, 20:4)    decreased in 2% of flaxseed oil- and 1-2% of fish oil-fed 
groups significantly.  
Conversion between ω-3 fatty acids 
The effect of short-chain ω-3 ALA-enriched flaxseed oil diet and long-chain ω-3 fatty 
acids-rich fish oil diet on liver DHA content is shown in Figure 2. DHA in duck liver became 
predominant in both fish oil and flaxseed oil groups. Among of ω-3 fatty acids, 91%, 92%, and 
85% were DHA in the liver of ducks fed various fish oil doses at 0.5%, 1%, and 2%, respectively. 
Meanwhile, 81%, 73%, and 59% of total ω-3 fatty acids were converted to DHA in the duck liver 
fed flaxseed oil at 0.5%, 1%, and 2%, respectively. When compared with fish oil group, 1% of 
flaxseed oil produced an equivalent level of DHA as 0.5% of dietary fish oil. 
Ratio of total ω-3/ω-6 fatty acids 
As shown in Figure 3, the ratios of Σω3/Σω6 in duck liver gradually increased as the doses 
of flaxseed oil or fish oil increased. Fish oil group possessed a higher Σω3/Σω6 value than flaxseed 
oil group at each dose, while a comparable value was observed between 1% of flaxseed oil and 
0.5% of fish oil treatment. 
 
 Discussion 
 Fatty acid manipulation via dietary means may provide an effective method to obtain 
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healthy animal products for humans. Our previous studies investigated the effect of dietary fat on 
fatty acid composition showing that different dietary fats could change ω-3 fatty acid composition 
in the duck eggs and muscle tissues. However, little information is available about ω-3 fatty acid 
profile in the liver modified by various dietary fats. Therefore, this present study, to our 
knowledge, is the first time to examine the modulation of different dietary fats on fatty acid profile 
and contents in the duck liver. 
After 5-week’s dietary treatment, all the dietary fats except for beef tallow showed 
significant modifications of the fatty acid profile and content in the duck liver. Although beef 
tallow provided more SFA than the control diet, no significant difference was found in 2% beef 
tallow-fed group, suggesting an effective transport and storage of SFA into non-hepatic tissues 
such as adipose tissues. Furthermore, the MUFA-enriched rapeseed oil treatment did not affect 
any fatty acids except for ALA that significantly increased in hepatic tissues. 
The most significant modification was observed in the groups fed with either flaxseed oil 
or fish oil. Ducks fed with flaxseed oil and fish oil diets were found to have much higher total ω-
3 PUFA and ω-3/ω-6 ratio than other groups. The ratio of ω-3/ω-6 was achieved as high as 0.28 
for flaxseed oil-fed group and 0.36 for fish oil-fed group. Such ratio is much higher than the 
modern Western diet and is compatible with that of our ancestors about 100-150 years ago.39 The 
increase of both ratios in flaxseed oil and fish oil groups directly not only due to the increase of ω-
3 fatty acids but also due to the decrease of ω-6 fatty acids, especially for AA. AA is a precursor 
of the derived eicosanoids such as PGE2, TXA2 and LTB4. The decrease of ω-6 fatty acids like 
AA may thus reduce risk of platelet aggregation, hemorrhage, and vasoconstriction.40-41 Some 
studies also suggested that a lower ratio of ω-3/ω-6 diets suppress inflammation in patients with 
rheumatoid arthritis,42,43 and have a beneficial effect on patients with asthma.44 The ω-3/ω-6 ratio 
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maybe a useful indicator to evaluate the healthy benefits of the functional food products. 
It is interesting that duck liver possesses an efficient conversion of all the short-chain ω-3 
fatty acids into long-chain DHA. About 60% of ALA in the flaxseed oil was converted to DHA in 
the duck liver, while 85% of total ω-3 fatty acids, mostly EPA and DHA, in the fish oil was 
converted to DHA. Such high conversion efficiency may be related to the broad substrate 
specificity of the duck elongase enzymes that convert the short-chain ω-3 PUFAs to final DHA 
exceptionally.23 
The results of dose response study showed that the total ω-3 fatty acids, specifically DHA, 
and the ratio of ω-3/ω-6 increased as the dose increased in both flaxseed oil and fish oil treatments. 
It should be noted that 60-81% of the short-chain omega-3 ALA in flaxseed oil-fed group was 
efficiently converted to long-chain DHA in the duck liver and 1% of dietary flaxseed oil produced 
an equivalent level of DHA or ω-3/ω-6 ratio as 0.5% of dietary fish oil. Therefore, the ducks fed 
flaxseed oil could be an alternative source of fish DHA. Considering that the cost of flaxseed oil 
is much less expensive than fish oil, it appears commercially applicable for flaxseed oil-enriched 
diet to be used by waterfowl to provide healthy products. 
Taken together, this study investigated the effects of various dietary fats on fatty acid 
profile and contents of ω-3 fatty acids in duck liver. Total ω-3 fatty acids and the ratio of total ω-
3/ω-6 significantly increased in both flaxseed oil- and fish oil-fed groups. About 60-81% of the 
short-chain ω-3 ALA in flaxseed oil-fed group was efficiently converted to long-chain DHA in the 
duck liver, whereas 1% of dietary flaxseed oil could produce an equivalent level of DHA as 0.5% 
of dietary fish oil. It is significant that the short-chain ALA was efficiency converted to long-chain 
DHA in the duck liver, which may provide an alternative DHA-enriched duck products for human 
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health benefits. 
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Table 3-1 Composition and main characteristics of the basal diet. 
Ingredients Content (g/kg)  Nutrient Content (g/kg) 
Maize grain 400 Metabolizable energy 11.2b 
Wheat 290  Crude protein 16.5 
Soybean meal 120  Total phosphorus 0.70 
Wheat bran 90  Total calcium 3.35 
Calcium hydrophosphate 12  Total lysine 0.79 
Stone powder 80  Total methionine 0.40 
Salt 3  Ether extract 29.0 
Premixa 5    
a Supplied per kg of diet: vitamin A 1,500 U, cholecalciferol 200 U, vitamin E (DL-α-tocopheryl 
acetate) 10 U, riboflavin 3.5 mg, pantothenic acid 10 mg, niacin 30 mg, cobalamin 10 μg, 
choline chloride 1,000 mg, biotin 0.15 mg, folic acid 0.5 mg, thiamine 1.5 mg, pyridoxine 3.0 
mg, Fe 80 mg, Zn 40 mg, Mn 60 mg, I 0.18 mg, Cu 8 mg, Se 0.3 mg; b Unit: MJ/kg 
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Table 3-2 Measured fatty acids in the experimental diets. 
Fatty acid* 
Content (g/100g total fatty acids) 
Control Flaxseed oil Rapeseed oil Beef tallow Fish oil 
SFA 32.6 25.5 26.2 41.9 30.4 
MUFA 37.8 33.0 48.5 36.9 45.7 
PUFA 29.8 41.6 25.4 20.3 35.1 
Total ω3 7.6 20.5 5.7 4.7 10.9 
18:3ω3 6.2 19.7 4.8 4.2 4.4 
20:5ω3 0.9 0.6 0.6 0.4 6.1 
22:6ω3 0.3 0.2 0.2 0.2 0.3 
Total ω6 19.3 19.1 17.8 13.3 14.2 
18:2ω6 18.8 18.7 17.4 12.9 12.7 
20:2ω6 0.1 0.1 0.1 0.1 0.8 
20:4ω6 0.5 0.4 0.3 0.3 0.7 
PUFA/SFA 0.9 1.6 1.0 0.5 1.2 
Σω3/ Σω6 0.4 1.1 0.3 0.4 0.8 
*SFA: Saturated fatty acids; MUFA: Monounsaturated fatty acids; PUFA: Polyunsaturated fatty 
acids. (This table is modified from our published paper45). 
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Table 3-3 Fatty acid contents in the duck liver fed various dietary fats for 5 weeks.* 
Fatty acid 
Content (mg/g fresh weight) 
Control Flaxseed oil Rapeseed oil Beef tallow Fish oil 
SFA 8.5±1.9 8.9±0.7 10.0±2.5 9.8±1.0 11.1±3.7 
MUFA 7.0±2.3 7.9±1.4 12.2±4.9 9.4±1.3 11.3±6.0 
PUFA 5.7±0.9a 7.8±0.5ab 8.0±2.2ab 6.3±0.6a 9.6±3.3b 
Total ω3 0.4±0.0a 1.7±0.1c 1.0±0.3b 0.3±0.0a 2.5±0.7d 
  18:3ω3 0.1±0.0a 0.7±0.2c 0.4±0.3b 0.1±0.0a 0.1±0.1ab 
  20:5ω3 UD 0.0±0.0a 0.0±0.0a UD 0.2±0.0b 
  22:6ω3 0.3±0.0a 1.0±0.1b 0.6±0.1a 0.3±0.0a 2.1±0.5c 
Total ω6 5.3±0.9 6.1±0.4 7.01±2.0 6.0±0.6 7.2±2.8 
  18:2ω6 2.5±0.7 3.9±0.6 4.6±2.1 3.3±0.7 5.4±2.7 
  20:2ω6 0.1±0.0 0.1±0.0 0.1±0.0 0.1±0.0 0.1±0.0 
  20:4ω6 2.8±0.3a 2.1±0.3b 2.4±0.3ab 2.6±0.2a 1.7±0.3c 
PUFA/SFA 0.7±0.1a 0.9±0.8b 0.8±0.1b 0.7±0.0a 0.9±0.0b 
Σω3/ Σω6 0.1±0.0a 0.3±0.0c 0.1±0.0b 0.1±0.0a 0.4±0.1d 
*Values are expressed as mean ± SD (n=3-6). Means in a raw without a common letter differ, 
p<0.05. 
**SFA: Saturated fatty acids; MUFA: Monounsaturated fatty acids; PUFA: Polyunsaturated fatty 
acids. UD: undetectable.  
(This table is modified from our published paper45). 
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Table 3-4 Fatty acid contents of duck liver fed various dose of dietary fats for 5 weeks.* 
 
Fatty 
acid** 
Content (mg/g fresh weight) 
Control Flaxseed oil Fish oil 
 0.5% 1% 2% 0.5% 1% 2% 
SFA 8.5±1.9 8.4±1.3 9.2±0.7 8.9±0.7 10.3±2.0 9.8±1.1 11.1±3.7 
MUFA 7.0±2.3 6.4±2.8 6.9±1.2 7.9±1.4 11.2±3.6 9.2±2.5 11.3±6.0 
PUFA 5.7±0.9 6.7±0.6b 7.8±0.7a 7.8±0.5a 7.4±1.5 8.0±0.4 9.6±3.3 
Total ω3 0.4±0.0 0.9±0.1c 1.5±0.2b 1.7±0.1a 1.2±0.2b 1.9±0.0ab 2.5±0.7a 
 18:3ω3 0.1±0.0b 0.2±0.1b 0.4±0.2a 0.7±0.2a 0.1±0.0 0.1±0.0 0.2±0.1 
 20:5ω3 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.1±0.0 0.2±0.1 
 22:6ω3 0.3±0.0 0.7±0.1b 1.1±0.1a 1.0±0.1a 1.1±0.2b 1.8±0.1ab 2.1±0.5a 
Total ω6 5.3±0.9 5.8±0.7 6.4±0.4 6.1±0.4 6.2±1.3 6.1±0.4 7.2±2.8 
 18:2ω6 2.5±0.7 2.6±1.1 3.4±0.5 3.9±0.6 3.7±1.2 3.7±0.6 5.4±2.7 
 20:2ω6 0.1±0.0 0.1±0.0  0.1±0.0 0.1±0.0 0.1±0.0 0.1±0.0 0.1±0.0 
 20:4ω6 2.7±0.3 3.1±0.4a 2.8±0.2a 2.1±0.3b 2.4±0.2a 2.2±0.2a 1.7±0.3b 
PUFA/SFA 0.7±0.1 0.8±0.1 0.9±0.0 0.9±0.1 0.7±0.1b 0.8±0.1ab 0.9±0.1a 
Σω3/ Σω6 0.1±0.0 0.2±0.0b 0.2±0.0b 0.3±0.0a 0.2±0.0b 0.3±0.1a 0.4±0.1a 
* Values are expressed as mean ± SD (n=6). Means in a raw without a common letter differ,  
p < 0.05.  ** SFA: Saturated fatty acids; MUFA: Monounsaturated fatty acids; PUFA: 
Polyunsaturated fatty acids. Values are expressed as mean ± SD (n=6).  
(This table is modified from our published paper45). 
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Figure legends 
Figure 3-1 Representative Gas Chromatography of fatty acid profile in the liver of ducks fed 
with various dietary fats for 5 weeks. Shan Partridge Ducks were randomly assigned into 5 
dietary treatments: either the basal diet or 2% of flaxseed oil, rapeseed oil, beef tallow, or fish oil, 
respectively. At the end of the 5-week treatment, fatty acids in duck liver were analyzed by GC-
FID.  
Figure 3-2 Dose response of ω-3 fatty acids in the liver of ducks fed with various doses of 
flaxseed oil or fish oil for 5 weeks. Shan Partridge Ducks were randomly assigned into a dose 
response study by feeding either flaxseed oil or fish oil diets at 0.5%, 1%, and 2%, respectively. 
At the end of the 5-week treatment, fatty acids in duck liver were analyzed by GC-FID. About 59-
81% and 85-92% of total ω-3 fatty acids were converted to DHA in the duck liver fed various 
doses of flaxseed oil and fish oil, respectively. The dose of 1% flaxseed oil produced an equivalent 
level of DHA as 0.5% fish oil. Values are expressed as mean ± SD (n=6). Means in a group without 
a common letter differ, p < 0.05. 
Figure 3-3 Dose response of total ω-3/ω-6 ratio in the liver of ducks fed with various disease 
of flaxseed oil or fish oil for 5 weeks. Shan Partridge Ducks were randomly assigned into a dose 
response study by feeding either flaxseed oil or fish oil diets at 0.5%, 1%, and 2%, respectively. 
At the end of the 5-week treatment, fatty acids in duck liver were analyzed by GC-FID. The ratios 
of ω3/ω6 in duck liver gradually increased as the doses of flaxseed oil or fish oil increased. Fish 
oil group possessed a higher ω3/ω6 value than flaxseed oil group, but a comparable value was 
observed between 1% of flaxseed oil and 0.5% of fish oil treatment. Values are expressed as mean 
± SD (n=6). Means in a group without a common letter differ, p < 0.05. 
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Figure 3-1 Representative Gas Chromatography of fatty acid profile in the liver of ducks 
fed with various dietary fats for 5 weeks. 
 
Note: This figure is modified from our published paper45. 
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Figure 3-2 Dose response of ω-3 fatty acids in the liver of ducks fed with various doses of 
flaxseed oil or fish oil for 5 weeks.  
 
Note: This figure is modified from our published paper45. 
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Figure 3-3 Dose response of total ω-3/ω-6 ratio in the liver of ducks fed with various 
disease of flaxseed oil or fish oil for 5 weeks.  
 
Note: This figure is modified from our published paper45. 
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Chapter 4 - Conclusions 
This dissertation focused on functional food related bioactive compounds with special 
interests in sorghum phenolic compounds and omega-3 polyunsaturated fatty acids.  
Study 1: Thirteen sorghum accessions were selected to test the effects of their phenolic 
extracts on cancer cell growth in vitro. In conclusion, this study shows that phenolic extracts in 
sorghum effectively inhibited HepG2 or Caco-2 cell growth in a dose- and time- dependent 
manner. The cell growth inhibition by the sorghum extracts were significantly associated with their 
phenolic contents. Furthermore, the inhibition appeared to be mediated by cytostatic, not 
cytotoxicity. Taken together, this study is the first time to investigate and compare the anti-cancer 
effect of sorghum phenolic compounds in both HepG2 and Caco-2 cell lines, our findings 
suggested that sorghum is a valuable food crop to provide sustainable phenolics and furthermore 
promote human health. 
Study 2: This study investigated the effects of various dietary fats on fatty acid profile and 
contents of ω-3 fatty acids in duck liver. Total ω-3 fatty acids and the ratio of total ω-3/ω-6 
significantly increased in both flaxseed oil- and fish oil-fed groups. About 60-81% of the short-
chain ω-3 ALA in flaxseed oil-fed group was efficiently converted to long-chain DHA in the duck 
liver, whereas 1% of dietary flaxseed oil could produce an equivalent level of DHA as 0.5% of 
dietary fish oil. It is significant that the short-chain ALA was efficiency converted to long-chain 
DHA in the duck liver, which may provide an alternative DHA-enriched duck products for human 
health benefits. 
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Chapter 5 - Future plan 
Study 1: This study was to investigate the effect of sorghum phenolic extracts on 
inhibiting of cancer cell growth and the underlying mechanisms regarding cytotoxicity, cell cycle 
interruption and apoptosis induction. First, this study was conducted in vitro which did not 
consider the possible metabolism of phenolics in vivo. Future study could be done in vivo to 
strengthen the conclusion that sorghum phenolic extracts could efficiently suppress cancer cell 
growth. Second, cell cycle analysis and apoptosis were tested using PI staining solution by flow 
cytometry, the results of which may influenced by factors such as loss of cells during the process 
of experiment. To further confirm the results, future work could focus on the level of cell cycle 
regulator proteins such as p34cdk2 and cyclin B1 which can be tested by western blot. In addition, 
apoptosis marker such as annexin V and PARP could be tested as well to confirm the result of 
apoptosis induction.  
Study 2: This study was to assess the modification of fatty acid profiles as well as 
investigate the conversion of short- to long-chain omega-3 polyunsaturated fatty acids in the 
liver of Shan Partridge duck after feeding various dietary fats. Future study could focus on the 
fatty acid profile in the liver of other poultry animals such as chicken and turkey since they are 
more popular than duck in the USA and some other countries in the western world.  
